



























































In' this' thesis' we' aimed' to' evaluate' the' ability' of' PI3K' overexpression' to' induce'
synaptogenesis'in'a'pathological'context'where'synapses'are'degenerated'due'to'Aβ42'
accumulation.'In'addition'we'analyzed'the'mechanism'underlying'PI3K'actions'in'Aβ42'







Synaptogenic' and' aggregation' effects' of' PI3K' in' Aβ42' neurodegeneration' are' also'
reproduced'in'human'neuroblastoma'cells,'proving'that'both'actions'are'conserved'in'
humans,'and'suggesting' that' it' could'be'considered' for' future' therapeutic' studies' in'
AD.'
In' addition,' discovery'of' a' transient'neuronal' enhancer' activation'event' in' epithelial'
cells' during' early' development' in' Drosophila,' helped' us' uncover' new' Aβ42' toxic'



















Los'efectos' sinaptogénicos'y'agregantes' causados'por'PI3K'en' la'neurodegeneración'
mediada'por'Aβ'también'son'reproducibles'en' las'células'de'neuroblastoma'humano'
(HT@SY5Y),' indicando'que'ambos'efectos'están'conservados'en'humanos'y'sugiriendo'
que' podría' ser' utilizado' en' estudios' terapéuticos' futuros' de' la' enfermedad' de'
Alzheimer.''
Por' último,' se' descubre' un' proceso' de' activación' transitoria' de' dos' enhancer'
neuronales'en'células'epiteliales'durante'el'desarrollo'temprano'en'Drosophila,'lo'que'
se'utilizó'para'identificar'un'efecto'tóxico'novedoso'de'Aβ42'en'células'no@neuronales.'
La'expresión'del'péptido'amiloide'activa' la'apoptosis'e' induce' la'desregulación'de' la'
vía'de'señalización'de'Wnt'en'células'epiteliales.'Ambos'efectos'deletéreos,'originados'













































































































































of" a"51" years/old" female"patient" called"Augusta"D." She"had" suffered" from"memory" loss,"
hallucinations,"disorientation"and"paranoia,"and"had"later"died"because"of"the"injuries"of"a"
stay/in/bed"condition"and"a"pulmonary"infection."In"her"brain,"Alois"Alzheimer"described,"
the" two"hallmarks"of" the"disease," extracellular"β/amyloid"plaques" (Aβ)," and" intracellular"
neurofibrillary"tangles"(NFTs)."His"discoveries"were"presented,"at"the"37th"meeting"of"the"
Society" of" Southwest" Germany" Psychiatrists" in" Tübingen." At" that" time," this" type" of"
dementia"was"thought"to"be"a"rare"disease;"more"than"a"century"later,"Alzheimer’s"disease"
is" the" most" prevalent" neurodegenerative" illness" in" the" world," affecting" an" estimated"
population" of" 46"million" people" today." As" recently" published" by" the"World" Alzheimer’s"




Known" by" being" the" most" common" type" of" dementia," Alzheimer’s" disease" (AD)" is"
characterized" by" a" progressive" neuronal" loss" that" causes" severe" cognitive" deficits" and"
neuropsychiatric" symptoms" which" induce" memory" loss," depression," anxiety," sleep"
alterations," hallucinations," aggressiveness" and" violence" among" other" symptoms" of"
neurodegeneration."The"diagnosis"of"patients"consists"in"the"proved"presence"of"amyloid/
β"and/or"tau" in"the"cerebrospinal"fluid"(CSF),"together"with"mini/mental"state"evaluation"
(MMSE)" for" cognitive" impairment"measure,"magnetic" resonance" imaging" (MRI)" for"brain"
volume"and"positron"emission"tomography"(PET)"scans"for"amyloid/β"plaques"and/or"brain"
glucose"metabolism"analysis.!










aging" the"main" risk" factor." Taking" into" account" that"AD"develops"over" a" long"preclinical"
period,"the"question"arises"if"instead"of"a"causative"relation,"the"disease"can"progress"due"
to" accumulative" risk" factors" assessed" in" late" or"mid/life" before" the" onset" of" the" clinical"
symptoms."Many"studies"are"carried"out" to"decipher" if" factors"as"vascular"health"status,"
diabetes," obesity," physical" and" mental" inactivity," depression," smoking," low" educational"




for" AD" in" homozygous" individuals," and" 20/30%" for" APOE3" and" APOE4" heterozygotes"
(Genin" et" al.," 2011)."APOE4" is" a" lipoprotein" that"mediates" cholesterol"metabolism" in" an"
isoform/dependent" manner." The" variant" E4" associates" with" atherosclerosis," cognitive"
impairment," AD," faster" multiple" sclerosis" progression" and" telomeres" shortening." The"
ABCA7" lipid" transporter" has" been" identified" as" another" genetic" risk" factor" for" AD"
(Hollingworth" et" al.," 2011)." APOE4" and" ABCA7" alleles" are" associated" with" less" efficient"
amyloid/β" clearance," but" in" both" cases," more" evidence" needs" to" be" compiled" to"
understand"the"biochemical"details"of"their"contribution"in"AD"pathology.!
Microglial" elements" of" the" complement" cascade" have" recently" been" described" also" as"
genetic" risks:" CR1," CD33" and" TREM2" increase" expression" upon" amyloid/β" plaques"
formation" (Bertram"et" al.," 2008," Lambert" et" al.," 2009," Suarez/Calvet" et" al.," 2016)." Some"
other"endosomal"vesicle"recycling"elements"implicated"in"APP"(amyloid"precursor"protein)"
processing," like" SORL1," BIN1" and" PICALM," have" been" similarly" associated" with" AD"
pathogenesis"(Rogaeva"et"al.,"2007,"Lambert"et"al.,"2013,"Zhao"et"al.,"2015)."!
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In" summary," all" these" factors" could"directly" or" indirectly" alter" amyloid/β"homeostasis" in"
late/onset" (previously" described" as" sporadic)" AD" patients," which" serves" as" a" proof/of/
concept" for" the" amyloid" hypothesis" as" the" mechanistic" process" underlying" Alzheimer’s"
disease,"that"will"be"addressed"below.!!
1.2!β<AMYLOID!PATHOPHYSIOLOGY!!





NFTs" were" discovered" in" 1986" (Grundke/Iqbal" et" al.," 1986)" and" described" to" be"
intraneuronal" fibrillar" aggregates" of" hyperphosphorylated" tau" protein." Tau" is" a"
microtubule/associated"protein"that,"upon"phosphorylation,"alters"microtubule"dynamics"
by"pathologically" increasing"their"stability,"and"as"a"consequence"leads"to"a" less"dynamic"
cytoskeleton" and" deficient" transport." Several" kinases" are" implicated" in"
hyperphosphorylation"of"tau,"including"GSK/3,"MAPK,"CaMKII"and"Akt."NFTs"are"not"only"a"
marker" of" Alzheimer’s" disease" but" also" a" hallmark" of" other" types" of" dementia" and"
neurodegenerative"diseases,"generally"referred"to"as"tauopathies.!
Aβ" peptide" is" the" only" exclusive" marker" of" AD" known" today." It" is" generated" from" the"
processing" of" the" full/length" amyloid" precursor" protein" APP," a" transmembrane" protein"
processed" in" two"sequential"proteolytic"cleavages"by"β"and"γ"secretases" (De"Strooper"et"
al.," 2010);" known" as" the" amyloidogenic" pathway." The" first" cleavage," mediated" by" β/
secretase,"generates"a"soluble"(sAPPβ)"fragment"and"a"βAPP/CTF"fragment."Subsequently,"










under" non/pathological" conditions." Only" when" the" equilibrium" between" its" production"
through" amyloidogenic" processing" of" APP," and" its" degradation" by" neprilysin," insulin"
degrading" enzyme" or" endothelin" converting" enzyme" (Turner" et" al.," 2004)" becomes"
imbalanced,"Aβ"is"regarded"as"a"synaptotoxin,"and"the"amyloid"cascade"is"initiated"(Hardy"
and"Higgins,"1992).!
Once" generated," the" Aβ" peptide" can" accumulate," oligomerize" and" aggregate."
Furthermore," the" initial" Aβ" molecules" can" suffer" modifications" as" truncations,"




to" protein" aggregation," which" involves" a" misfolding" process" of" Aβ" into" soluble" and"
insoluble" assemblies." Aβ" innocuous" monomers" are" composed" by" α/helical" and/or"
unordered" structure," while" Aβ" polymers" have" β/sheet" conformation" that" promote"
homophilic" interactions"leading"eventually"to"toxic"oligomer"formation"(Pike"et"al,"1991).""
As" the" nucleation/dependent" polymerization" model" states," monomers" can" suffer"
conformational"changes"of"self/assembly"and"generate"oligomers"in"a"thermodynamically"
unfavorable" manner." The" resulting" oligomers" can" then" associate" and" create" oligomeric"
nuclei" that" elongate" and" assemble" larger" aggregates" in" a" more" favorable" and" rapid"
process."The"concentration"of"nuclei,"or"seeds,"is"crucial"for"determining"the"lag"phase"of"




the"different"Aβ"species"differ" in" toxicity" (Goure"et"al.,"2014)."Monomers"are" innocuous,"
but"as"they"self/associate" into"oligomers"and"pre/fibrillar"aggregates," they"become"toxic."
Insoluble"Aβ"plaques"are"now"considered"rather"benign"species"that"could"serve"as"a"sink"
but" also" a" potential" source" of" toxic" soluble" oligomers" (Caughey" and" Lansbury," 2003,"
Stefani,"2010,"Moreth"et"al.,"2013,"DaRocha/Souto"et"al.,"2011).!
Thus,"there"are"three"different"Aβ"pools"with"different"aggregation"kinetics"that"can"cause"




to" elucidate" whether" Aβ" is" accumulated" extracellularly," intracellularly" or" in" both"
compartments."!
The"amyloid"cascade"hypothesizes"that"plaques"can"sequester"Aβ"oligomers"until"reaching"




in" AD" patients" (Engelborghs," 2013," Goedert," 2015)." On" the" other" hand," intracellular"
accumulation"has"also"been"found"in"high/resolution"electron/microscopy"studies"in"brain"
samples" of" AD" patients," where" Aβ" appeared" inside" of" the" cell" at" synaptic/terminals"
(Gouras"et"al.,"2010)."!
Classical" extracellular" localization" of" Aβ" deposits" occurs" as" a" consequence" of" initial" APP"
amyloidogenic"proteolysis"by"β/secretase"cleavage" in"the"extracellular"domain."Next," the"
subsequent" cleavage" of" the" intramembranous" domain" by" γ/secretase" releases" the" Aβ"
peptide"into"the"extracellular"space"or"vesicle"lumen"(Shoji"et"al.,"1992,"Haass"et"al.,"2012)."
Intracellular" deposits" have" also" been" detected" in" several" studies" (Wirths" et" al.," 2004,"
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Crowther"et"al.,"2005,"LaFerla"et"al.,"2007,"Zhao"et"al.,"2010)."Their"nature"has"not"yet"been"
fully" clarified," as" they" could" be" a" result" of" endosomal" membrane/APP/derived" Aβ"
aggregates," or" they" could" be" on" the" process" of" secretion," targeted" for" lysosomal"
degradation"or"even"a"result"of"a"later"uptake"of"previously"secreted"Aβ"oligomers.!
Whether" the" first" toxic" source" of" oligomers" is" the" extracellular" β/amyloid" or" the"
intracellular"β/amyloid"is"a"question"still"under"debate."!!
1.3!Aβ<MEDIATED!SYNAPTOTOXICITY!
Aβ" oligomers" are" gradually" accumulated" in" limbic" and" association" cortices," where" they"
cause" subtle" effects" to" synapse" efficacy." Higher" deposition" of" oligomers" can" induce" the"
formation"of" diffuse"plaques" that" later"promote"microglial" and"astrocytic" activation" and"





It" is" well" documented" that" Aβ" oligomers" produce" early" synaptic" alterations" that" later"
develop" into" dramatic" synapse" loss." Although" strong" efforts" have" been" directed" to" the"
study" of" the" mechanisms" by" which" β/amyloids" elicit" synaptotoxicity," it" is" still" today" a"
matter"of"deep"analysis,"as"it"seems"a"very"complex"sequence"of"events.!
LTP" (Long" Term" Potentiation)" and" LTD" (Long" Term" Depression)" electrophysiological"
recordings" of" synaptic" strength" and" plasticity" have" shown" interesting" results" upon" Aβ"
oligomer’s"exposure."They"measure"activity/dependent"reduction"of"efficacy"in"synapses"in"
NMDAR"(N/methyl"D/aspartate"receptor)"/dependent"long/term"potentiation"and"NMDAR/
dependent" long/term" depression," respectively." Several" studies" have" proved" that" Aβ"
impairs"LTP"(Walsh"et"al.,"2002,"Cleary"et"al.,"2005)"but"increases"LTD"(Hsieh"et"al.,"2006)"
causing" synaptic" depression." The"mechanisms"by"which"Aβ" enhances" LTD" are" still" to" be"
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completely" elucidated," but" they" comprise" receptor" internalization," desensitization" or"
activation"of"perisynaptic"receptors"that"lead,"eventually,"to"spine"loss."
Although"electrophysiological"recordings"have"highlighted"the"synaptotoxic"actions"of"Aβ,"
it" is" still" an" open"question"whether" they" act" in" specific" sets" of" cells" or" synapses" or" not."
Several" membrane" receptors" have" been" proposed" to" act" as" specific" targets" of" Aβ" in"
neurons:"NMDA"(De"Felice"et"al.,"2008,"Decker"et"al.,"2010),"the"prion"protein"(PrP)"(Lauren"
et"al.,"2009)," the"metabotropic"glutamate/5" receptor" (mGluR5)" (Renner"et"al,"2010)," the"
receptor" for" advanced" glycation" end/products" (RAGE)," the" neurotrophin" receptor" p75"
(Yaar"et"al.,"1997),"the"α7"nicotinic"acetylcholine"receptors"(α7/nAChR)"(Wang"et"al.,"2000,"
Dineley"et"al.,"2001),"the"postsynaptic"membrane"associated"protein"PSD/95"(Pham"et"al.,"
2010)," the" Ephrin/type" B2" receptor" (EphB2)" (Cisse" et" al.," 2011)" and" Ephrin/type" A4"





noticeable" in" the"entorhinal" cortex"and" the"hippocampus," regions" implicated" in" learning"
and"memory."!
Experimental"evidence"supports"that"Gabaergic"neurons"could"be"more"vulnerable"to"Aβ,"
and" that" β/amyloids" could" act" inhibiting" network" excitation" by" suppressing" synaptic"
transmission" strength"and" short/term"plasticity" (Palop"and"Mucke,"2010)." In" contrast," in"
vivo"studies"in"hAPP"(human"APP)"transgenic"mice"show"evidence"of"epileptic"activity"upon"
Aβ" exposure," in" EEG" recordings" from" cortex" and" hippocampus" (Palop" et" al.," 2007)."
Furthermore,"cell"culture"and"cortical"slices"have"shown"to"increase"their"activity"after"Aβ"
treatment" (Palop" et" al.," 2007)." These" results" suggest" that" Aβ" can" also" elicit" aberrant"
excitatory"changes"in"neuronal"circuits."This"fact"could"generate"a"positive"feedback"loop,"






and" vulnerability" to"Aβ" (Palop"and"Mucke," 2010)."Moreover,"AD"progression"appears" to"
affect"different"processes"at"different"stages"of"the"disease.""!
1.4!EMERGING!HYPOTHESES!FOR!ALZHEIMER’S!














characteristic" cognitive" decline" and" synaptic" loss" (Inestrosa" and" Varela/Nallar," 2014)." β/






Taken" together," all" these" data" suggest" that" dysregulation" of" insulin" and"Wnt/β/catenin"




been" very" intense" in" the" last" years." In" particular," synapse" maintenance" is" critical" for"
delaying" the" loss" of" spines" and" synaptic" function" that" occurs" along" the" normal" ageing"
process.!
Protein" kinases" are" involved" in" plasticity" mechanisms" like" neurogenesis," modulation" of"
intrinsic"excitability,"long/lasting"strengthening"of"pre/existing"synapses"or"synaptogenesis."
Some" of" them" are" calcium/calmodulin/dependent" kinase" II" (CaMKII)," cAMP/dependent"
protein"kinase"A"(PKA),"cGMP/dependent"protein"kinase"(PKG),"phosphoinositide/3"kinase"
(PI3K)," cyclin/dependent" kinase" 5" (CdK5)," protein" kinase" C" (PKC)" and" brain" atypical" PKC"





receptor" trkB." This" activation" is" critical" for" long/term" memory" (LTM)" formation" as" the"
impairment"of"PI3K/Akt"signaling" in"trkB"mutants"suppress"LTM"(Musumeci"et"al.,"2009)."
mTOR"(mammalian"target"for"rapamycin)"and"GSK3/β,"downstream"effectors"of"PI3K/Akt"
pathway,"have"also" important" functions" in" LTM"and"memory"consolidation"and" retrieval"
(Bekinschtein"et"al.,"2007,"Hooper"et"al.,"2008,"Hong"et"al.,"2012,"Huang"et"al.,"2013).!
Furthermore,"PTEN" inhibition" in"hippocampal"and"cortical" regions"of"mice" showed"over/
activation" of" Akt" signaling," causing" macrocephaly," severe" dendritic" dystrophy" and"
dramatic"increase"in"spine"density"(Kwon"et"al.,"2006).!
Previous"data"from"our"lab"have"shown"that"PI3K"and"Akt"activation"elicit"the"increase"of"
synapse"number" in" larval"NMJs" and" adult" brain" interneurons" and"projection"neurons" of"
Drosophila* melanogaster" (Martin/Pena" et" al.," 2006," Acebes" et" al.," 2011," Acebes" et" al.,"
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(PSDs)" and" glutamate" receptors" (Jordan/Alvarez" et" al.," 2012)." Other" elements" of" the"
canonical"PI3K/Akt"pathway" like"PTEN,"FoxO"and"mTOR,"had"no"effect" in" the"number"of"
synapses," suggesting" that" a" specific" pathway" for" synapse" number" regulation" was" being"




and" Type" II" BMP" receptor" Wit" (wishfull" thinking)" are" key" regulators" of" synaptic"
development"and"maturation"in"the"Drosophila"NMJ"(Berke"et"al.,"2013)."
Using" the"Drosophila" larval"NMJ," data" from"our" lab" have" shown" that" PI3K/synaptogenic"
actions" are" part" of" a" larger" signaling" pathway," connected" with" other" previously" known"
elements" including:" the" Wit" receptor," its" ligand" Gbb" (glass" bottom" boat)," and" the"
MAPkinases"cascade." In"addition,"an"antagonistic"pathway"uses" the" transcription" factors"
Mad" and"Medea," the" co/factor" Yorkie" and" the"microRNA" bantam" to" down/regulate" key"
elements" of" the" pro/synaptogenic" pathway." Like" its" counterpart," this" anti/synaptogenic"
pathway"also"makes"use"of"a"small"GTPase"and"MAPKs"signals"including"Ras/like/a,"p38"and"
Licorne." Thus," the" number" of" synapses" results" from" the" balanced" output" from" the" two"
signaling"pathways.""
Interestingly," the" PI3K/Akt" signaling" pathway" is" well/conserved" across" species" (Ruggero"
and" Sonenberg," 2005)" and" PI3K" synaptogenic" actions" have" recently" been" tested" in"
mammals"with"PTD4/PI3KAc"administration"(chapter"3"for"details),"resulting"in"conserved"
functions"producing"up/regulation"of"synaptic"spines"in"mice"primary"hippocampal"neuron"




transportation" of" synaptic" components" necessary" for" synapse" formation," maintenance,"
growth" and" function." Disruption" of" intracellular" transport" has" resulted" in" synaptic"
morphological" abnormalities" and" BMP" signaling" perturbations" (Kang" et" al.," 2014)."
Similarly,"direct" regulators"of"cytoskeleton"dynamics"have" important"effects" in"synapses."
For" instance," GSK3/β" can" regulate" microtubule" dynamics" by" stabilizing" Futsh;" Wingless"
(Wg)"regulates"planar"cell"polarity"(PCP)"by"activation"of"Dvl"(Dishevelled)"and"c/Jun"kinase"
(JNK)"that"directly"controls"microtubule"stability."BMP"can"also"regulate"the"cytoskeleton"






synapse" number" in" addition" to" their" well/known" roles" on" cell" survival" and" cell" growth,"
thus,"knowing"that"synapse"loss" is"one"of"the"first"steps"leading"to"neurodegeneration"in"
AD,"and" that" the"accumulation"of"β/amyloid"peptides" from"the"APP"has"been" related" to"
the" onset" of" the" pathology," the" aim" of" this" thesis" pose" the" question" of" whether" PI3K"
synaptogenic"actions"could"be"effective"against"the"synaptotoxic"effects"of"Aβ42,"both"in"
Drosophila* studies" and" in" a" human" neuroblastoma* in* vitro" system." The" potential"
synaptogenic"actions"of"PI3K"will"be"addressed"in"an"adult/onset"AD"model"in"Drosophila"
ausing" the"binary"Gal4/UAS"expression"system," together"with" the"Gal80ts" repressor."This"
strategy"will"allow"space"and"temporal"control"of"the"human"Aβ42"peptide"expression"in"
the" nervous" system." Furthermore" the" scope" will" include" the" search" for" novel" non/













(KPI)" and" an" E2" domain." The" intracellular" region" contains" the" YENPTY" motif." The" Aβ"
sequence"is"in"the"transmembrane"region,"between"the"YENPTY"motif"and"the"E2"domain.!
Across" species,"Aβ" sequence" is"only" found" in" the"human,"Mus*musculus" and"Dario* rerio"
(Appa)"homologs."Together"with"APLP1"and"APLP2,"Caenorhabditis*elegans"and"Drosophila*
melanogaster" homologs" lack" the" Aβ" sequence." The" absence" of" Aβ" conservation" across"










formation" and" neuromuscular" junction" (NMJ)" appearance" (Torroja" et" al.," 1999a)." APPL"
overexpression" produces" axonal" transport" disruption" by" interacting" with" kinesin" heavy"









PI3K"or"phosphoinositide/3"kinase" is"an" intracellular"family"of"proteins"that" includes"four"
different" classes:"Class" I" are"heterodimers"of"a" catalytic" subunit" (p110)"and"a" regulatory"
subunit" (p85)," responsible" for" the"production"of"PI(3)P,"PI(3,4)P2"and"PI(3,4,5)P3."Class" II"
members" have" three" catalytic" subunits" and" no" regulatory" subunits." Class" III" are"
heterodimers" composed" of" a" catalytic" subunit" (Vps34)" and" a" regulatory" subunit"
(Vps15/p150)" that" are" involved" in" vesicles" and" protein" trafficking." Finally," Class" IV" are"
serine/threonine" kinases" like" mTOR," DNA/dependent" protein" kinase" (DNA/PK)," among"
others.!
PI3K"constitutes"a"cell/signaling"crossroad,"as"it"is"implicated"in"proliferation,"survival,"cell"
growth,"motility," differentiation," and" intracellular" transport" (Grundke/Iqbal" et" al.," 1986,"
Engelman"et"al.,"2006,"Acebes"and"Morales,"2012,"Knafo"and"Esteban,"2012,"Menon"et"al.,"
2014)."The"canonical"activation"of"PI3K"is"mediated"by"RTKs"(Receptors"of"tyrosine"kinases)"
phosphorylation" and" the" subsequent" recruitment" and" conformational" change" of" PI3K"
heterodimers."These"events"allow"the"phosphorylation"of"the"catalytic"subunit"triggering"










numerous" studies" during" decades" to" address" synaptic" plasticity" mechanisms" and"
development" (Keshishian" et" al.," 1996)." However," to" evaluate" neurodegeneration" and" to"
distinguish" from" developmental" defects," the" adult" NMJ" is" a"more" suitable" tissue." Adult"
ventral" longitudinal" muscle" (VLM)" NMJs" have" been" characterized" (Hebbar" et" al.," 2006,"
Wagner"et"al.,"2015).!
VLM"NMJs" have" one" single" nerve" entry" point" innervating" the"muscle" and" present" large"
glutamatergic"boutons" (Hebbar"et" al.," 2006)."VLM"NMJs" synapses" consist"of"presynaptic"
active"zones"(AZs)"and"associated"postsynaptic"membranes"(Wagner"et"al.,"2015)."AZs"are"
specialized" membrane" compartments" at" the" axonal" terminal" where" neurotransmitter"




Munc/18," SNAREs," SNAP25," Synaptobrevin/VAMP" and" syntaxin;" cell" adhesion"molecules"
like"SYG/1/Neph1,"SYG/2/Nephrin,"Neurexin"and"Neuroligin;"actin"and"tubulin"cytoskeletal"
components" like" actin," tubulin," myosin," spectrin," β/catenin" and" WVE/1/WAVE" complex"
(Sudhof,"2012).!
In"vertebrates,"NMJs"contain"elongated"AZs"to"which"neurotransmitter"containing"vesicles"
attach." Invertebrate" NMJs" are" similar" to" central" vertebrate" synapses," although" they"










cycle," lower" cost," smaller" body" size" and"more" importantly" a"wide" spectrum"of" available"
genetic" tools" that" allow" faster" genetic" screens;"moreover"Drosophila" can" be" use" to" test"
candidate"therapies"and"drugs"(Rincon/Limas"et"al.,"2012,"Ugur"et"al.,"2016).!
Fly" models" of" AD" have" been" generated" following" different" strategies." Some" studies"
coexpress" human" APP" and" human" BACE" (β/secretase)," and" describe" consequent" Aβ"
plaques" formation" and" age/dependent" neurodegeneration" (Greeve" et" al.," 2004)" with"
decreased" presynaptic" connections," altered" mitochondrial" localization" and" reduced"
postsynaptic"protein"levels"(Mhatre"et"al.,"2014).!
Other"models" are" based"on" the"human"β/amyloid" peptide" expression." For" this" strategy,"






et" al.," 2011)," consisting" in" a" bi/cistronic" system" (2" tandem" copies)" of" the" human" Aβ42"
fused"to"a"secretion"signal."This"model"shows"extensive"neuronal"cell"death"and" induces"
XBP1" unconventional" splicing." The" 2x/UAS/Aβ42" genetic" construct," allows" stronger"
neurotoxic" phenotypes" that" develop" faster" than" in" other" 1/copy"models," facilitating" the"
search"for"suppressor"candidates.!




Aβ" expression," which" can" produce" APP" transport" alterations" by" affecting" kinesin/1" and"
dynein"(Weaver"et"al.,"2013)."Others"have"shown"that"GSK3/β"inhibition"can"restore"some"
of"the"Aβ"toxic"effects,"as"well"as"lithium"or"Congo/Red"treatment"(Crowther"et"al.,"2004,"
Sofola" et" al.," 2010," Sofola/Adesakin" et" al.," 2014)." However," other" authors" found" no"
restoration"when"they"down/expressed"shaggy"(the"Drosophila"homolog"of"GSK3/β)"in"Aβ"
expressing" neurons," claiming" no" Wnt/Aβ" interaction" in" Drosophila" AD" models"
(Luchtenborg"and"Katanaev,"2014)."PI3K"inhibition"by"down/expression"of"p65"regulatory"












3. To" study" of" the" synaptogenic" actions" of" Medea" down/regulation" and" mTOR"
overexpression"in"Aβ42/mediated"neurodegeneration"
4. To"characterize"a"novel"effect"of"PI3K"activation"in"Aβ42"aggregation"


















































gene" of" interest" (gene" X)" under" the" regulation" of" UAS" sequences" (Upstream"Activating"
Sequence)."
To"report"the"activity"of"specific"enhancers"we"have"used"‘enhancer/trap"Gal4"lines’."These"













promoter" (tub8Gal80ts)," the" activation" and" repression" of" the" Gal4/UAS" system" can" be"
regulated" by" temperature." Gal80ts" protein" is" not" functional" at" 29°C," so" the" Gal4/UAS"
system" is" active" at" this" temperature." On" the" other" hand," Gal80ts" is" functional" at" 17°C,"
repressing"the"Gal4/UAS"(McGuire"et"al.,"2003)."
! 25"
This" construct" is" highly" instrumental" in" situations"where" the" gene" of" interest" is" causing"
toxic" or" lethal" effects" that" restrict" the" study" to" early" stages" of" development." In" these"
situations,"Gal80ts"can"be"used"to"activate"the"expression"of" the"gene"of" interest"only"at"
later" stages"of"development."This"was" the"case" in" the"study"of" the" toxic"effects"of"Aβ42"
during"development."








The" Gal4" technique" for" real/time" and" clonal" expression," or" G/TRACE" analysis" system,"




the" expression"of"Act>GFP" (green)" in" these" cells" and," thus," expressing" the"GFP" reporter"
independently"from"the"enhancer"that"controlled"the"Gal4"driver"under"study."In"this"way,"









































Antibody! Tech.! Protein! Species! Dilution! Source!
nc82" IHC" Bruchpilot" mouse" 1:20" DSHB"
hrp" IHC" Horseradish"peroxidase" rabbit" 1:200" DSHB"
! 27"







csp/3" IHC" Activated"caspase/3" rabbit" 1:100" Cell"
Signaling"
wg" IHC" Wingless" mouse" 1:20" DSHB"
pH3" IHC" phospho"Histone/3" rabbit" " Millipore"
arm" IHC" armadillo" mouse" 1:50" "
elav" IHC" Elav" mouse" 1:50" DSHB"
pSer" IHC" phospho/Serine" mouse" 1:200" Abcam"
pTyr" IHC" phospho/Tyrosine" rabbit" 1:200" Abcam"
pSer8/Aβ" IHC" phospho/Serine8/Aβ42" mouse" 1:1000" Jochen"Lab"
pSer26/Aβ" IHC" phospho/Serine26/Aβ42" rat" 1:1000" Jochen"Lab"
β/Tub" WB" β/Tubulin" mouse" 1:10000" Abcam"
" " " " " "
Secondary!Antibodies!
Alexa"488" IHC" Alexa"Fluor"488"dye" mouse" 1:300" TFS"
Alexa"568" IHC" Alexa"Fluor"568"dye" rabbit" 1:300" TFS"




SH/SY5Y" human" neuroblastoma" cells" were" purchased" from" ATCC" (ref:" CRL/2266)." Cells"
were" seeded" at" 5x104" cells/cm2" and"used"when" cultures" reached" a" 70–80%" confluence."
Culture" media" contained" RPMI" (Sigma/Aldrich," USA)" supplemented" with" 0.5" mM"
glutamine"(Sigma/Aldrich,"USA),"penicillin"(50"mg/ml)/streptomycin"(50"U/ml)"from"Sigma/








The" peptide" includes" a" PTD$/transduction" domain" that" allows" membrane"
permeabilization," PTD4" (Tyr/Ala/Arg/Ala/Ala/Ala/" Arg/Gln/Ala/Arg/Ala)," (Ho" et" al.," 2001),"
fused"to"a"phosphopeptide"containing"the"intracellular"phosphorylated"SH2"domain"of"the"
PDGF" receptor" (Gly/Ser/Asp/Gly/Gly/pTyr/Met/Asp/Met/Ser)," (Derossi" et" al.," 1998)." This"
peptide"has"been"shown"to"induce"class"I"PI3K"activation,"independently"of"tyrosine"kinase"









formic"acid," in"200"μl"of"hexafluoroisopropanol" (HFIP)" for"20"min."at" room"temperature."







Ten" fly" heads" from"each" genotype"were" used" to" prepare" homogenates." Fly" heads"were"
homogenized" in" 20" μl" of" lysis" buffer" containing" PBS1x," Triton" 1%," 150" mM" NaCl" and"
Complete" Protease" Inhibitors" (Roche)." Equal" volume" of" Tricine/SDS" and" 5%" β/
mercaptoethanol" loading" buffer" was" added" to" each" sample." Later," the" samples" were"
boiled" at" 95°C" for" 5"min." Protein" extracts"were" fractionated"by" sodium"dodecyl" sulfate/












resuspended" in" 30" μl" of" PBS" with" 1%" Triton" X/100" and" 30" μl" 70%" formic" acid." After"
30"
sonication," vortex" shaking" and" 800" rpm" centrifugation" for" 1"min.," the" supernatant" was"
dried"with"SpeedVac"for"1"hour."The"dried"pellet"was"finally"resuspended"in"40"μl"of"PBS"





to" total," insoluble" or" soluble" protein" fractions." The" samples" were" then" sonicated" and"








qPCR" analysis" was" done" using" 7500" Real" Time" PCR" System" (Applied" Biosystems)" with"





in" phosphate/buffered" saline" for" 20" minutes," washed" 3" times" with" 0,1%" triton," and"





7/day" old" and" 15/day" old" female" fly" brains" were" fixed" in" 4%" formaldehyde" and"



















allowing" the" Gal4/UAS" system" to" activate" the" expression" of" the" corresponding" genes"
thanks"to"the"inactivation"of"the"Gal80ts"repressor."Females"were"separated"and"placed"in"
plastic" vials" containing" ten" to" fifteen"of" them,"and"kept" at" 29°C," 70%"humidity," under" a"
12/12/h" light/dark" cycle." The" counting"was"done"at" 25°C"every"2/3"days" in" a"plastic" vial"
that"was"gently"tapped"to"the"bottom."The"number"of"flies"that"reached"the"4"cm."high"line"
was"counted"after"10"sec."of"climbing;"at"the"same"time,"the"number"of"flies"that"started"
climbing" but" did" not" reached" the" 4cm" line," and" the" number" of" flies" that" stayed" at" the"







kept" at" 29°C," 70%"humidity," under" a" 12/12/h" light/dark" cycle." Food" vials"were" changed"
32"


















Synapses" were" revealed" by" the" primary" mouse" monoclonal" antibody" nc82," which"
recognizes"the"CAST"homolog"bruchpilot"protein,"a"constituent"of" the"active"zone"of" the"




To" quantify" the" active" zone" area," total" nc82" positive" signal" was" measured" in" the" third"
segment" VLM/NMJs" (adult" ventral" longitudinal" muscle" neuro" muscular" junctions)" with"
Imaris"(Bitplane)"software."This"estimation"procedure"was"required"as"some"of"the"mutant"






SH/SY5Y" human" neuroblastoma" cells" were" seeded" in" a" 96/well" plate" when" cultures"
reached" a" 70–80%" confluence," and" incubated" overnight" with" RPMI" culture" media"
supplemented"with" 10%" FBS" (see"Materials" for"more" details)." Cells" were" differentiated"
with" retinoic" acid" (10μM)" and"RPMI" containing" 2%" FBS." 24h" later," PTD4/PI3KAc"peptide"
was" added" to" the" wells" for" pre/treatment" studies." Aβ42" oligomers" were" added" to" the"
media"24h"after"the"first"treatment"of"PTD4/PI3KAc."For"co/treatment"experiments,"PTD4/
PI3KAc"peptide"was"added"at"the"same"time"as"Aβ42"oligomers."Finally,"for"Post/treatment"
studies," PTD4/PI3KAc" peptide" was" added" to" the" media" 24h" after" oligomer" addition."







supplemented"with" 10%" FBS" (see"Materials" for"more" details)." Cells" were" differentiated"
with"retinoic"acid"(10μM)"and"RPMI"containing"2%"FBS"for"48"hours"prior"to"the"addition"of"
any" stimuli." Aβ42" oligomers" (36μg/ml)" and" PTD4/PI3KAc" (50μg/ml)" were" added" to" the"








1. Cells" supernatant" was" transferred" to" a" new" well," with" a" coverslip," after" 48h" of"
differentiation."Aβ42"oligomers"were"added"to"the"supernatant"and"incubated"for"
48h" before" immunstaining." This" experiment" was" an" internal" control" for" Aβ42"
aggregation."
34"
2. Differentiated" cells" were" treated" with" PTD4/PI3KAc" and" incubated" for" 48h," the"
supernatant" was" then" transferred" to" a" new" well," with" a" coverslip," were" Aβ42"
oligomers" were" added" and" incubated" for" another" 48h" prior" to" immunostaining."
This"experiment"was"named"PI3K"pre/treatment."
3. The" Supernatant" of" differentiated" cells" was" transferred" to" a" new" well," with" a"
coverslip,"after"48h"of"differentiation."In"the"new"well,"the"supernatant"was"treated"
with" PTD4/PI3KAc" and"Aβ42" oligomers" at" the" same" time," and" incubated" for" 48h"
before"immunostaining."This"experiment"was"named"PI3K"co/treatment."
4. Differentiated"cells"were"treated"with"Aβ42"oligomers"for"48h"prior"to"transfer"the"
supernatant" to" a" new" well," with" a" coverslip." The" supernatant" was" then" treated"
with" PTD4/PI3KAc" and" incubated" for" another" 48h" before" immunostaining." This"
experiment"was"named"PI3K"post/treatment."





Statistical" significance" was" calculated" using" a" unpaired" Student's" two/tailed" t/test," with"





















CHAPTER!6!! STUDY!OF!THE!SYNAPTOGENIC!ACTIONS!OF!MEDEA!! ! !


















8.1" Aβ42/induced" Inflated" abdomen" phenotype" is" prevented" by" PI3K"
" overexpression"
8.1.1" The" nervous" system" enhancer" elav" is" transiently" active" in" epithelial"
cells!of"the"wing"disc"




8.3"PI3K"overexpression"reduces"Aβ42/induced"apoptosis" in"epithelial" cells"of" the"
wing"disc"




! ! ! ADULT<ONSET!AD!MODEL!
!
Previous" studies" have" demonstrated" the" synaptogenic" functions" of" PI3K" in" invertebrate"
and"mammal"neurons"(Martin/Pena"et"al.,"2006,"Acebes"et"al.,"2011,"Cuesto"et"al.,"2011)."
These" new" synapses" were" functional" and" supernumerary," as" quantified" in" larval" NMJ"
active"zones"(Martin/Peña"et"al,"2006;"Jordan/Alvarez"et"al,"2012),"and"adult"antennal"lobe"
inhibitory" interneurons" in" Drosophila" (Acebes" et" al.," 2011)," and" in" CA1" hippocampal"
cultured" neurons" in" mice" (Cuesto" et" al.," 2011)." Thus," PI3K" overexpression" becomes" a"
synaptogenic" tool" than" could" be" used" in" pathological" situations" where" synapses" are"
affected.""
In" this" work" we" ask" if" the" synaptogenic" functions" of" PI3K" are" effective" in" a"





constitutively" active" form" of" PI3K" and" the" human" Aβ42" peptide" within" the" pan/neural"
pattern" of" the" elav/Gal4" driver." To" discard" an" effect" during" development," we" used" the"





and" dissected" adult" abdomens" to" later" visualize" the" third" segment" ventral" longitudinal"






At" 7" days" (Fig.! R1"A/D,E)," all" genotypes" had" similar" numbers" of" synaptic" area," and" no"
significant"changes"were"found,"suggesting"that"neither"of"the"genotypes"(Aβ42,"PI3K,"or"
PI3K/Aβ42)" had" altered" synapse" formation." However," at" a" later" time/point," Aβ42"
expressing"flies"showed"significant"decrease"in"the"total"synaptic"area"when"compared"to"
matching" controls" that" had" reached" 15" days." At" the" same" time," PI3K" flies" showed" a"
significant"increase"in"total"synaptic"surface,"in"concordance"with"previous"published"data"
(Martín/Peña" et" al," 2006)." Interestingly," PI3K" and" Aβ42" co/expression" showed" very"
significant"differences" compared" to"Aβ42" (Fig.!R1!A’/D’,E)." This" recovery" in" the" synaptic"
area"indicated"that"the"synaptogenic"effect"of"PI3K"could"prevent"the"synapse"loss"induced"
by"Aβ42"in"adult"motor"neurons"at"day"15"of"expression."PI3K/Aβ42"showed"no"significant"
changes" when" compared" to" control" flies," meaning" that" the" synapses" in" PI3K/Aβ42"
genotype"stayed"in"the"similar"values"than"control"healthy"flies.""
Observing" puncta" morphology," we" noticed" that" Aβ42" flies" showed" disorganized" non/
spherical"positive"dots"of"bruchpilot"signal" (Fig.!R1!C’)."This"deposit/like"morphology"was"






D’’,E)." At" 25" days," PI3K" flies" maintained" significantly" larger" values" of" synaptic" area"
compared" to"matching"controls."At" this" time/point"PI3K/Aβ42"genotype"was" still" able" to"
keep" similar" values" of" synaptic" area" to" controls," and" no" significant" differences" were"
observed"between" the" two"groups." These" results" suggest" that" PI3K" expression"prevents"
Aβ42" synaptotoxic" effects" also" at" later" time/points." Taking" into" consideration" that"
PI3K/Aβ42" flies" died" under" these" conditions" soon" after" 25" days" (Chapter" 5)," we" can"
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conclude" that" PI3K" effects" in" preventing" Aβ42" synaptotoxicity" are" effective" in" an" age/
independent"manner."






elimination," we" wondered" first" if" the" transcription" of" synaptic" genes" was" affected."
Quantitative" RT/PCR" using" mRNA" from" adult" heads" was" used" to" analyzed" three" AZs"
components:"bruchpilot," liprin" and" synaptobrevin" (Kidokoro," 2003," Fouquet" et" al.," 2009)"
mRNA"levels."Flies"from"all"the"genotypes"in"the"study"were"aged"to"15"days"with"the"same"
adult/onset"design"used"in"previous"experiments.""







To" this" end," we" performed" live" time/lapse" imaging" in" whole/mount" larvae" to" analyze"





EB1/GFP" comets"of" third" instar" larval" ddA" (dendritic" arborization"dorsal" cluster)" sensory"





E,F)." Values" of" track" length" and" track" duration" did" not" change" in" any" of" the" studied"
genotypes"(Fig.!R3!G,H).""
Moreover," we" analyzed" track" density" by" counting" the" number" of" comets" relative" to"
dendritic" surface," as" the" EB1/GFP" overexpression" allows" some" background" signal" that"
serves" as" a" reporter" of" the" dendritic" size" (Fig.! R3)." Aβ42" expressing" neurons" showed" a"
significant" decrease" in" comet" density" compared" to" controls." Interestingly," PI3K" and"
PI3K/Aβ42" did" not" show" significant" changes" when" compared" to" controls" (Fig.! R3! I),"
indicating"that"PI3K/Aβ42"was"able"to"prevent"the"decrease"in"comet"density"induced"by"
Aβ42."
The" absence"of" significant" changes" in" track" length" and" track"duration" indicates" that" the"
growing"process"of"the"microtubule,"once"started,"is"affected"neither"by"Aβ42"nor"by"PI3K"
or"PI3K/Aβ42"expression"(Fig.!R3!G,H)."The"polymerization"of"tubulin"units"to"the"growing"




We" conclude" from" these" findings" (Fig.! R3)" that" Aβ42" produces" changes" in"microtubule"
dynamics" by" reducing" the" number" of" growing" events" per" surface" unit,"which" is" a" direct"
evidence"of"intracellular"transport"deficits."Interestingly,"PI3K/Aβ42"neurons"had"the"same"
number"of"growing"microtubules"per"surface"unit"as"control,"pointing"that"PI3K"activation"




! ! ! OF!PI3K!OVEREXPRESSION!IN!Aβ42!INDUCED!! ! !
! ! ! NEURODEGENERATION!
!
The"promising" results" shown" in"chapter"4"urged"us" to" further"analyze" the"effect"of"PI3K"
overexpression" at" a" whole" organismal" level." In" other" Drosophila" AD" models,"
neurodegenerative"phenotypes"have"been"characterized"by"locomotion"performance"and"
lifespan"studies."In"order"to"compare"our"adult/onset"Aβ42"overexpression"model"with"the"
rest" of" AD" models" described," and" to" evaluate" if" PI3K" activation" can" protect," not" only"




To" test" if" the" protected" synapses" were" functional" when" Aβ42" was" expressed" in"
combination"with"PI3K,"we"analyzed"locomotion"performance"in"adult"flies."















The" total" number" of" flies" that" climbed" above" the" line" was" reduced" in" Aβ42" flies" when"
compared" to" matching" controls" and" PI3K." This" effect" was" delayed" with" PI3K/Aβ42"
expression"(Fig.!R4!B/E)."
Pie"charts" for"15"days"and"20"days"data"show"more"specific"values" (Fig."R4!F/M)."As" the"
flies" aged," the" locomotor" affectation" became" more" evident" in" all" genotypes." Aβ42"
genotype" showed" a" very" rapid" reduction" of" the" climbing" performance" that" was" also"
aggravated" in" time." PI3K/Aβ42" genotype" developed" also" a" reduction" in" the" climbing"









control" (Fig.! R5! B)." On" the" other" hand," PI3K" overexpression" alone" showed" significant"
increase"in"survival"(Fig!R5!A)."PI3K"overexpression"when"combined"to"Aβ42,"significantly"
ameliorated" the" negative" lifespan" effect" attributed" to" Aβ42" (Fig.! R5! D)." However," this"
recovery" in" survival" did" not" reach" control" values," and" significant" differences" were"
observed"when"PI3K/Aβ42"was"compared"to"controls"(Fig.!R5!C)."
Taken"together," these"data" (Fig.!R5)" indicate"that"PI3K"overexpression"ameliorates"Aβ42"
lifespan"reduction."The"recovery" in"survival,"although"very"significant"when"compared"to"





Knowing" that" PI3K" synaptogenic" actions" are" conserved" in" human"neurons," and" that" our"




Cells" were" grown" and" differentiated" with" retinoic" acid" and" 1%" serum" for" 48h" prior" to"
stimulation" with" treatments." Once" differentiated," neurons" were" treated" with" Aβ42"
oligomers."As"expected,"treatment"with"Aβ42"oligomers"/"reduced"viability"after"48"hours."
To" stimulate" PI3K" activity" in" these" cells" and" evaluate" cell" viability,"we" used" the" peptide"
PTD4/PI3KAc,"which"was"previously"proved"to"trigger"PI3K"activation"both" in"vitro"and"in"
vivo" (Cuesto" et" al.," 2011," Enriquez/Barreto" et" al.," 2014)." PTD4/PI3KAc" peptide" was"
administered" at" 3" different" time" points," naming" the" 3" time/point" treatments" as" 1)" pre/
treatment," 24h" before" Aβ42," 2)" co/treatment," at" the" same" time" as" Aβ42" and" 3)" post/
treatment,"24h"after"Aβ42."
Aβ42"oligomers"where"prepared" following"Kayed"&"Gable,"2006"protocol" (see"chapter"3"
for" details)" and" added" to" the" cell" culture" 72" hours" after" cell" seeding" (48" hours" after"
differentiation)," at" 3" different" concentrations," to" study" the" potential" effects" of" PI3K"
activation"under"these"conditions."
The" percentage" of" cells" alive" after" the" treatment"with" Aβ42" oligomers"was" significantly"





the" treatment" occurred" 48h" or" 72h" after" differentiation," but" produced" a" significant"
increase" in" viability" when" administer" 24h" after" differentiation." This" effect" can" be"
attributed" to" the"brief" period"of" starvation" and"differentiation" that" the" cells" had" at" this"




induced" cell" death" when" administer" either" before" or" at" the" same" time" than" Aβ42"









CHAPTER!6!! ! STUDY!OF!THE!SYNAPTOGENIC!ACTIONS!OF!MEDEA!! !
! ! ! DOWN<REGULATION!AND!mTOR!OVEREXPRESSION!IN!Aβ42!!
! ! ! NEURODEGENERATION!
!
Activation"of"PI3K"proved" to"prevent"Aβ42/induced"synapse" loss"and"delayed" locomotor"
performance" deficits," as" well" as" ameliorated" longevity," as" shown" in" bruchpilot"
quantification"in"adult"NMJs,"climbing,"and"lifespan"assays,"respectively."Furthermore,"SH/
SY5Y" cells" were" also" protected" from" Aβ42/induced" cell" death"when" PI3K"was" activated"
before"or"together"with"Aβ42"treatment."
Being" PI3K" at" the" crossroads" of" many" pathways," one" could" argue" that" the" preventive"
effects"shown"by"the"overexpression"of"this"kinase"could"be"explained"by"the"activation"of"
the" canonical" pathway" of" PI3K," that" is" known" to" elicit" pro/survival" and" cell" growth"
responses."Thus,"we"wondered"if"classical"effectors"of"PI3K"pathway"could"reproduce"the"
protective" functions" of" PI3K," or" if" on" the" other" hand," more" synaptogenic" proteins"
previously" proved" to" increase" synapse" number," could" attain" the" preventive" actions" of"
PI3K."
"
6.1! Synaptogenic! proteins,! but! not! canonical! PI3K! effectors,! prevent! Aβ42<induced!
synapse!loss!!
To"explore" the"PI3K"partners" in" the"neuroprotective"effect"against"Aβ42," synapses"were"
quantified"when"mammalian"Target"of"Rapamycin"(mTOR),"a"downstream"protein"of"the"
canonical"pathway"of"PI3K/Akt,"was"overexpressed."mTOR,"does"not"exhibit"synaptogenic"
effects" when" overexpressed" in" Drosophila" NMJs" (Martín/Peña" 2007)," and" thus" is" not"
considered"a"player"in"the"synaptogenic"pathway."Using"the"same"procedure"as"in"Chapter"
4.1,"the"total"bruchpilot"signal"was"quantified"from"adult"abdominal"NMJs"of"15"days/old"









Synapse" surface" was" also" evaluated" with" Medea" down/expression." Medea" is" an" anti/
synaptogenic"protein,"homolog"of"human"Smad"4""(Hudson"et"al.,"1998),"that"binds"to"Mad"








These" observations" (Fig.! R7)" indicate" that" MedeaRNAi," but" not" mTOR," prevents" Aβ42/





in" combination"with"MedeaRNAi" urged" us" to" analyze" the" functionality" of" these" flies" in" a"
locomotor"assay."
The" same"procedure"used" in"Chapter"5.1"was"applied" to"mTOR,"mTOR/Aβ42,"MedeaRNAi"
and"MedeaRNAi/Aβ42"genotypes"(Fig.!R8!A)."











Taken" together" these" data" (Fig.! R8)" indicate" that" other" synaptogenic" agents," such" us"





Already" known" the" longevity" effects" of" PI3K" in" Aβ42" flies," we" wondered" if" mTOR"
overexpression"or"Medea"down/expression"could"also"be"affecting"Aβ42"flies"lifespan."
To"address"this" issue,"survival"studies"were"conducted"following"the"same"protocol"as" in"
Chapter" 5.2," this" time" with" mTOR," mTOR/Aβ42," MedeaRNAi" and" MedeaRNAi/Aβ42"
genotypes."




MedeaRNAi/Aβ42," on" the" other" hand," blocked" the" Aβ42" reduction" effect" in" lifespan,"
showing"no"significant"differences"when"compared"to"control"flies"(Fig.!R9!D)."MedeaRNAi"
alone" demonstrated" no" significant" differences" either" (Fig.! R9! C)." Comparing" Aβ42" and"
MedeaRNAi/Aβ42"lifespan"we"found"a"very"significant"increase"(Fig.!R9!F),"as"expected"from"
previous"comparisons"of"MedeaRNAi/Aβ42"with"control"flies."







and" PI3K" overexpression," two" synaptogenic" strategies," to" counteract" the" degenerative"


























To" confirm" this" result," same"aged" adult" heads" homogenates"were" analyzed"by"Western"
blot" (Fig.! R10! E)." Quantification" of" the" total" Aβ42" protein" showed" " 2.5" fold" increase" in"
PI3K/Aβ42"compared"to"Aβ42"alone."
In" order" to" investigate" a" putative" effect" in" transcription," qRT/PCR" was" performed" with"
same" aged" adult" head" homogenates" and" the" results" showed" no" changes" in" total" Aβ42"
mRNA,"discarding"this"possibility"(Fig.!R10!F)."
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Therefore," these" data" indicate" (Fig.! R10)" that" PI3K" overexpression" causes" a" total" Aβ42"






PI3K/Aβ42,"could"be"explained"by"having"a"higher"proportion"of" insoluble,"and" thus" less"
toxic,"aggregates."
To"prove"this"hypothesis"we"stained"7"and"15"days/old"brains"with"Thioflavin/S"(Fig.!R11!B/
C’)," a" dye" that" specifically" binds" to" proteins" with" β/sheet" conformation." The" dye" labels"











Having" previously" proved" that" PI3K" activation" can" prevent" Aβ42/induced" cell" death,"we"
wondered" if" the" aggregation" effect" that" PI3K" elicits" in" Aβ42" conformers" could" also" be"
reproduced"in"human"neurons.!
To"assess"that,"we"cultured"and"differentiated"human"neuroblastoma"cells"(SH/SY5Y)"with"
retinoic" acid" and" 2%" serum" for" 48h" prior" to" stimulation" with" the" treatments." Once"
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differentiated," neurons" were" treated" with" Aβ42" oligomers" (36μg/ml)" and" PTD4/PI3KAc"
peptide"(50μg/ml)"(see"Chapter"3"for"details)."Cover/slides"were"used"in"the"seeding"plates"
to" later" perform" immunostainings" with" 6E10" antibody." Cells" were" treated" with" both"
stimuli"added"at"the"same"time"and"incubated"for"48h."Afterwards,"cells"were"fixed"with"
formaldehyde" 4%" following" a" standard" protocol" of" immunostaining" (Fig.! R.12! A)." 6E10"
positive" deposits" were" counted" and" surface" per" deposit" was" measure" with" the" Imaris"
software."
As"expected,"no"6E10"positive"deposits"were"found"in"cells"treated"either"with"vehicles"or"
with" PTD4/PI3K" alone" (Fig.! R12! E/F’)." For" practical" reasons" only" Aβ42" and" PTD4/
PI3KAc/Aβ42"experiments"were"compared"(Fig.!R12!G/H’)."
PTD4/PI3KAc" in" combination" with" Aβ42" oligomers" treatment," showed" a" significant"
decrease"when"comparing"the"total"number"of"deposits"found"in"Aβ42"treatment"(Fig.!R12!
B)." Interestingly," the" total" surface" of" deposits" did" not" change" between"Aβ42" treatment"
and" PTD4/PI3KAc" +" Aβ42" treatment" (Fig.! R12! C)." However," deposit" surface" distribution"
showed" that" in"PTD4/PI3KAc"+"Aβ42" treatment" there"were"bigger"deposits" that"differed"
from"Aβ42"treatment"by"threefold,"fourfold"and"even"six"fold"increase"in"size"(Fig.!R12!D)."
These"data"(Fig.!R12)"indicate"that"the"Aβ42"aggregative"properties"shown"by"PI3K"in"adult"






deposits" are" generated," we" designed" a" set" of" experiments" to" decipher" if" PTD4/PI3KAc"
peptide"was"indeed"capable"to"promote"Aβ42"aggregation"extracellularly."
Following" a" previously" described" protocol," human" neuroblastoma" cells" (SH/SY5Y)" were"
cultured"with" retinoic" acid" and" 2%" serum" for" 48h" prior" to" stimulation"with" treatments."
Once" differentiated," neurons" were" treated" with" Aβ42" oligomers" (36μg/ml)" and" PTD4/
PI3KAc"peptide"(50μg/ml)"(see"Chapter"3"for"details)."
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Four" different" culture" classes" were" designed:" 1)" internal" control" for" Aβ42" oligomers"
aggregation,"2)"Aβ42"oligomers"with"PTD4/PI3KAc"pre/treatment,"3)"Aβ42"oligomers"with"
PTD4/PI3KAc" co/treatment," and" Aβ42" oligomers" with" PTD4/PI3KAc" post/treatment" (Fig.!
R13! A)." Supernatants" were" stained" with" 6E10" antibody," and" analyzed" with" Imaris"
software."
The" internal" control" of" Aβ42" oligomers" showed" no" significant" 6E10" positive" deposits,"







of" deposits/deposit" area”" was" studied" (Fig.! R13! D)." When" more" detailed" analysis" was"
performed," in"order" to"evaluate" the"deposit" surface"distribution" (Fig.!R13!E)," PTD4/PI3K"
co/treatment"showed"a"twofold,"fourfold"or"even"a"ten/fold"increase"in"deposit"size,"when"





Aβ42" deposits" that" range" from" two" to" ten/fold" increments" in" size." These" findings" also"




Knowing" that" phosphorylation" has" been" documented" to" be" one" of" the" factors" that" can"
affect"Aβ42"seeding"in"the"initial"phase"of"the"plaque"formation,"we"argue"that"PI3K"kinase"
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activity" could" be" directly" affecting" this" phosphorylation" and" thus" inducing" Aβ42" plaque"
seeding."
To" test" this" hypothesis," we" looked" for" residues" suitable" to" be" phosphorylated" in" Aβ42"
according" to" the" NetPhos" 2.0" Server" prediction" software" (www.cbs.dtu.dk)." This" study"
suggested" 3" putative" residues:" pSer8" (Score:" 0.963)," pTyr10" (Score:" 0.870)" and" pSer26"
(Score:"0.787)"(Fig.!R14!A)."
Phospho/Tyrosine"and"phospho/Serine"specific"antibodies"were"used"in"15"days/old"brains"
in" order" to" analyze" changes" in" the" signal" in" the" four" genotypes" under" study." Confocal"
images"(Fig.!R14!B/E’)"indicated"that"only"in"PI3K/Aβ42"brains"(Fig.!R14!E,E’)"the"phospho/
Serine" signal" was" incremented." Interestingly," the" phospho/Serine" signal" in" PI3K/" Aβ42"
brains" had" deposit/like" morphology." Phospho/Tyrosine" signal" was" very" similar" in" all"
genotypes"and"no"deposit/like"morphology"was"found"(Fig.!R14!F/I’)."
Co/localization"of"6E10"and"both"phospho/Serine"and"phospho/Tyrosine"was"not"feasible"
due" to" the" requirement" of" formic" acid" for" 6E10" immunostaining," which" strongly" alters"
phospho/peptides"and"membrane"stability"(data"not"shown)."




The" NetPhos" 2.0" Server" predicts" two" different" serine" residues" that" could" become"




(Fig.! R15! A’’,B’’)." Phospho/Ser26/Aβ42" immunostainings" showed" deposits" with" positive"
signal"in"both"Aβ42"and"PI3K/Aβ42"(Fig.!R15!A’,B’)."Unfortunately,"pSer26/Aβ42"antibody"
could"not"give"direct" results"due" to" the" fact" that" it" can"detect"both"phosphorylated"and"
non/phosphorylated"Aβ42."
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Taken" together," these" data" (Fig.! R15)" indicate" that" PI3K" does" not" trigger" the"
phosphorylation" of" Aβ42" in" residue" serine" 8," proved" by" immunostaining" with" the" only"

















accumulations," as" the"UAS/Aβ42"construct" consists"of" two" tandem"copies"of" the"human"
Aβ42" sequence" fused" to" a" peptide" signal" for" secretion," and" the" Aβ42" oligomers" were"









checked" if"PI3K" co/expression"could"prevent" these"potential"deleterious"effects." For" this"




To" our" surprise," adult" flies" overexpressing" Aβ42" with" the" pan/neural" elav/Gal4" driver,"
together"with" the" temperature" sensitive"Gal80ts" construct,"which" allowed" expression" of"
the"UAS/Aβ42"only"after"adult"eclosion,"showed"a"largely"inflated"abdomen"as"they"aged"
(Fig.! R16!A,B)." To" our" knowledge," this" is" the" first" report" of" Aβ42" causing" an" abdominal"
phenotype" in" flies."We"also"observed" that" the" flies"presented"not/retractable"proboscis,"
and"that"this"phenotype"did"not"appear" in"PI3K/Aβ42"flies"(Fig.!R16!C)."By"contrast,"PI3K"
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the"secretory"system" in" flies,"we"wondered" if" this"could"be"the"case" for"Aβ42."To"assess"
that,"we"overexpressed"Aβ42"in"abdominal"leucokinergic"cells"(leucokininM7/Gal4),"a"set"of"
peptidergic" neuro/secretory" cells" that" extend" their" projections" to" the" CNS" and" the"
periphery," where" they" reach" abdominal" muscle" 8." The" terminals" of" these" cells" do" not"
present"bouton/like"structures"and"they"lack"synapsin"and"sybsynaptic"reticulum"(Landgraf"
et"al.,"2003)."
The" overexpression" of" Aβ42" in" leucokinin" cells" reproduced" the" increase" in" abdominal"
volume"previously"described"with"elav/Gal4"driver"(Fig.!R16!D,E)."Furthermore,"PI3K/Aβ42"
combination"prevented"the"inflation"phenotype"(Fig.!R16!D,E)."The"loss"of"retraction"in"the"
proboscis" of"Aβ42" flies"was" also"observed"with" leucokinin/Gal4" driver," and" akin" to" elav/
Gal4,"PI3K/Aβ42"prevented"this"effect"(Fig.!R16!F)."These"observations"suggest"that"Aβ42"




However," the" elav/Gal4" expression" domain" with" which" the" non/neuronal" Aβ42"
phenotypes"were"identified"was"at"odds"with"the"widely"accepted"neuronal"specificity"of"




The" Drosophila" gene" elav," orthologue" of" ELAVL" gene" family" in" humans," is" expressed"
throughout"the"brain"(Robinow"and"White,"1988,"Van"Tine"et"al.,"1998,"Han"et"al.,"1996,"




(red" positive" cells)" and" historical" (green" positive" cells)" records" of" elav*enhancer" activity"
showed"high"correspondence"between"both"signals."These"data"indicate"that"cells"fated"to"





signals" demonstrate" that" the" elav" enhancer" had" been" expressed" in" wing" disc" cells"
sometime"along"development."
To"determine"at"what"stage"during"development"this"ectopic"enhancer"activation"occurs,"
we"analyzed"1st" and"2nd" instar" larvae"wing"discs" (24" and"48"hours" after" egg" laying,"AEL)"
(Figure!R17!C/D’)."G/TRACE"reporters"showed"that"the"elav"enhancer"was"active"as"early"as"
1st"(Figure!R17"C,C’)"and"2nd"(Figure!17!D,D’)"instar"larvae."Red"and"green"cells"are"found"in"
the" wing" disc" suggesting" that" the" enhancer" activity" is" triggered" at" the" initial" stages" of"
development."
Together," these"results" indicate"that"the"elav"enhancer" is"active" in"epithelial"cells"during"
development"and"maintains"its"activity"by"the"third"larval"instar,"albeit"to"a"lesser"extent,"
as" RFP/positive" cells" are" less" numerous" than" GFP/positive" cells" (Fig.! R17! A/D’)." GFP/
positive"cells" represent" the"wing"disc"cells"where" the"enhancer"has"been"active"at" some"
point" during" development," but" has" eventually" become" inactive." RFP/positive" cells"
represent" the" wing" disc" cells" where," at" the" moment" of" dissection," elav" enhancer" was"
active.""
We" noticed" that" the" expression" pattern" of" GFP" and" RFP" cells" across" different" discs" of"
different" larvae" was" not" reproducible." Although" this" variability" could" result" from"
heterogeneous" environmental" conditions" among" individuals," we" further" evaluated" this"
feature"comparing"left"and"right"wing"discs"from"the"same"individual."The"number"of"GFP/
positive" cells"was" comparable"between" the" two"wing"discs"of" the" same"animal," yet," the"
pattern"differs"(Figure!R17!E/F,G)."Moreover,"we"compared"left"and"right"wing"discs"of"the"




left" and" right" wing" discs," and" no" RFP/positive" cells" were" detected." GFP" and" RFP" cells"
patterns"differed"also"when"we" compared"elav/Gal4"enhancer" inserted" in"Chr." III" versus"
elav/Gal4"in"Chr."II."(Fig.!R17!E/I,"J)."
This" result" (Fig.! R17! E/J)" supports" the" notion" that" the" elav" enhancer" activation" during"
development" is" not" a" deterministic" phenomenon" and" it" rather" appears" to" be" a" random"
process.""
Finally,"to"determine"if"the"ectopic"wing"disc"expression"of"the"elav*enhancer"induces"the"
expression"of"Elav"protein,"we"stained" larval" tissues"with"anti/Elav"antibody."Third" instar"
larval"brains"showed"that"elav"enhancer"is"active"in"neurons"as"expected"(Figure!17!K)"and"
brain" cells" express" Elav" protein" (Figure! 17! K’)." However," while" wing" discs" show" elav"
enhancer"activity"(Figure!17!L),"the"Elav"protein"staining"was"negative"(Figure!17!L’).""
These" results" suggest" that" early" ectopic"wing" disc" activation" of" elav*enhancer" does" not"
imply" transcription"of" the"corresponding"gene,"at" least"as" judged"by" its"encoded"protein"
(Fig.!17!K/L’)."
"
8.1.2!Toll26! enhancer! (D42<Gal4)! is! transiently! activated! in!wing! imaginal! discs! during!
first!12h!after!egg<laying"
To"test"if"the"phenomenon"observed"with"the"elav"enhancer"is"general"to"other"enhancers,"
we" selected" the" line" D42/Gal4," which" corresponds" to" a" Toll86" gene" enhancer" (Sanyal,"
2009)," as" another" case" also" described" as" nervous" system" specific." Neurons" in" the" third"
instar"larval"brain"activated"D42"during"early"development"(Figure!R18!C)."Similar"to"elav,"
D42" is" also" activated" in"wing"disc" cells" during"early"development"but"not" at" third" instar"




Gal80ts," and" analyzed" the" resulting" G/TRACE" pattern" for" D42" enhancer" (Fig! R18! A)." As"
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controls," we"maintained" the" larvae" at" 17°C" (negative" control," Figure! R18! D)" or" at" 29°C"
(positive" control,"Figure!R18!H)." The"negative" control" shows"no"G/TRACE" signal" and" the"
positive"control"yields"full"enhancer"expression"in"the"brain."We"set"five"time"points"(OFF,"
12hOFF," 24hOFF," 48hOFF" and" ON)" corresponding" to" the" hours" that" the" system" is" kept"
silenced"(Fig.!R18!A)."Our"results"show"that,"if"the"system"is"silenced"during"48h"(Fig.!R18!
E),"24h" (Fig.!R18!F)"or"12h" (Fig.!R18!G)"of" larval"development," the"ectopic"expression"of"







adult" wing"morphology" was" normal" (Figure! R19"A/H)." These" results" suggest" that," even"
though"the"Toll6"enhancer"D42"shows"activity"in"the"wing"disc"during"development,"Toll6*
gene" expression" is" not" switched" on" during" wing" development," at" least" to" the" point" of"
manifesting"a"visible"phenotype"in"disc"size,"shape,"wg"pattern"or"adult"wing"morphology."
To"further"determine"if"the"ectopic"enhancer"expression"implies"a"transient"expression"of"
another" gene" under" UAS" control," we" used" Basket* (Bsk)." This" gene" product" induces"
apoptosis"by"driving"a"core"component"of"the"JNK"pathway,"(Moreno"et"al.,"2002)."Driven"
under"D42/Gal4"we"stained"with"anti/caspase/3"and"with"anti/Wingless" to"evaluate"wing"
disc" development." The" early" activation" of" D42/Gal4/Toll86" lead" to" Bsk/dependent"
apoptosis," as" revealed" by" caspase/3" staining," to" abnormalities" in" the" Wg" pattern" and"
resulted"in"defective"adult"wings"(Fig!R19!E/I)."







given" gene" in" epithelial" cells" of" the" wing" disc" during" early" development." The" transient"




Taking" advantage" of" the" transient" activation" of" elav/Gal4" and" D42/Gal4" enhancers" in"
epithelial"cells,"we"wondered"if"Aβ42"also"elicits"defects"in"tissue"growth"and"development"





































Nallar,"2014)," and" some"of" these"elements"have"also"been" implicated" in" synaptogenesis"
(Franciscovich"et" al," 2008)."Being" the"wing"disc"of"Drosophila" a" very" suitable" system" for"
signaling"studies,"we"investigated"if"Aβ42"and"PI3K/Aβ42"could"affect"Wnt"signaling."






the" wing" disc," both" in" PI3K/Aβ42" and" control" areas" (Fig.! R22! B,B’)." Furthermore,"
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Knowing" that" in" AD" synapse" loss" is" one" of" the" first" steps" in" the" progression" of" the"
neurodegenerative" process," and" that" previous" studies" have" demonstrated" the" age"
independent"synaptogenic"actions"of"PI3K" in" in*vitro"and" in*vivo" studies" (Martin/Pena"et"
al.," 2006," Acebes" et" al.," 2011," Cuesto" et" al.," 2011)," we" studied" the" potential" beneficial"
effects"of"PI3K"overexpression"in"an"adult/onset"model"of"AD"in"Drosophila."
Taking" advantage" of" the" binary" Gal4/UAS" expression" system," in" combination" with" the"
Gal80ts"construct,"that"allows"temporal"control"of"the"Gal4"protein"synthesis"(see"Chapter"
3)," human" Aβ42" peptide" was" expressed" in" the" nervous" system" of" adult" flies." The"
importance"of"this"experimental"design"rise"from"the"fact"that"Aβ42"expression"is"inhibited"
during" the" developmental" stages" of" Drosophila" (embryo," larva" and" pupa)" and" is" only"
activated"when" flies" reach"adulthood"and"eclosionate" from" their"puparium."Other" study"
has" used" a" similar" strategy" with" the" GeneSwitch" system" (Sofola" et" al.," 2010)," which"
controls" Gal4/UAS" system" activation" by"mifepristone" (RU486)" treatment." However," the"
majority"of"AD"models,"in"Drosophila"and"other"organisms,"follow"constitutive"expression"
of" the" Aβ" peptide," APP," PS1," tau," in" their"mutated" or"wild" type" forms" (Ashe" and" Zahs,"
2010," Wisniewski" and" Sigurdsson," 2010," De" Felice" and"Munoz," 2016)." Aβ42" formation,"
although" achieved" at" all"moments" in" life," is" only" known" to" exhibit" toxic" effects"when" it"







pathological" context" were" synapses" are" toxically" affected" by" Aβ42." Morphological"
observation" of" active" zones" (Bruchpilot" puncta)" across" genotypes" and" time/points"
demonstrated"that"Aβ42"expression"at"15"days"elicits"ultraestructural"misorganization"of"
AZs," and" that" PI3K/Aβ42" combination" reverted" this" defect." Presynaptic" affectation" by"
66"
Aβ42" has" not" been" as" deeply" studied" as" the" postsynaptic" effects," where" Aβ42" directly"
interacts" with" NMDA," mGluR5," PrP," p75" and" other" receptors" (Benilova" et" al.," 2012)"
impairing"LTP"and"inducing"LTD"enhancement"(see"Chapter"1"“Introduction”)."Thus,"direct"
effects" in" the" presynaptic" region," or" in" postsynaptic" densities," that" could" therefore"






Our" results" could" be" a" consequence" of" an" indirect" interaction" between" PI3K" and" Aβ42,"





when" studied" in" AD" models," PTEN" can" be" targeted" by" Aβ42" to" synaptic" spines."
Furthermore," pharmacological" administration" of" a" PTEN"membrane/permeable" peptide,"
unable" to" interact" with" Aβ42" through" PDZ" domains," rescues" the" synaptic" deterioration"





and" therefore" regulate"microtubule" dynamics" (Llorens/Martin" et" al.," 2014)" therefore," it"
has"become"one"of"the"most"tested"therapeutic"targets"in"AD."
PIP3,"synthetized"by"PI3K,"regulates"PSD/95"accumulation"and"synaptic"AMPA"receptors"in"
spines," affecting" synaptic" strength" (Arendt" et" al.," 2010)." In" this" line," cyclic" adenosine"
monophosphate" (cAMP)" response" element/binding" protein" (CREB)" has" been" showed" to"






(bruchpilot," liprin" and" synaptobrevin)," although" transcriptional" regulation" cannot" be"
excluded" from" the" possible" mechanisms" associated" to" Aβ42" and" PI3K." These"
transcriptional"alterations,"or"even"post/transcriptional"regulations"could"modify"synaptic"










the" number" of" growing" events," leading" to" a" less" dynamic," and" thus" ineffective,"
cytoskeleton."This"would"suggest"that"Brp"transport"to"the"AZ"could"be"affected"and"might"
explain"the"reduced"synaptic"area" in"adult"NMJs."More" importantly,"PI3K"overexpression"















Synapse" quantification," locomotion" assay" and" lifespan" performance" of" flies" expressing"
Aβ42" together" with" mTOR," showed" that" this" non/synaptogenic" tool" failed" to" restore"





in" our" lab" have" confirmed" that" Medea" participates" with" its" molecular" partner," Mad"
(mother" against" decapentaplegic)" in" the" same" synaptic" signaling" cascade" that" PI3K,"
although"they"have"opposing"roles.""Medea"is"considered"an"antisynaptogenic"protein,"and"
thus,"we"decided"to"test" its"downexpression," to" increase"synapse"number"and"study"the"
effects" in" our" Aβ42" model." Interestingly," Medea" downregulation" resulted" in" synapse"





that"PI3K"can"mediate"many"other" intracellular"processes."Hence," it" is"possible" that"pro/
survival"signaling"could"also"cause"the"beneficial"actions"that"PI3K"exhibits" in" lifespan." In"
the" future," further" studies"will" address" this" issue" and" decipher"whether" synaptogenesis"
and"survival"cues"can"be"separated."
PI3K/Akt/mTOR"signaling" is"conserved"across"phyla" (Ruggero"and"Sonenberg,"2005),"and"
so" seem" to" be" PI3K" synaptogenic" actions," since" studies" in" Drosophila,"mice" and" human"
cells"have"corroborated"this"fact"(Cuesto"et"al.,"2011,"Jordan/Alvarez"et"al.,"2012,"Enriquez/
Barreto"et"al.,"2014)."Moreover,"in"this"work"we"have"evaluated"the"preventive"actions"of"






it" restores" synapses" locomotion" and" lifespan" of" Aβ42" affected" flies." In" addition,"Medea"
downregulation"has"shown"to"block"BMP"signaling"(ref)"which"is"in"turn"altered"in"AD"(ref)."
On"the"other"hand,"mTOR"appears"to"enhance"the"neurotoxic"effects"of"Aβ42"in"lifespan,"
and" when" overexpressed" alone," showed" similar" reduction" in" synapses" than" Aβ42" flies."
These" findings" go" in" the" same" line"of" published"data" from"other" labs,"where"mTOR"has"







Aβ42" assemblies," leading" to" a"more" insoluble" aggregative" pattern" change." Interestingly,"
this" increase" in" insoluble" Aβ42" species" correlates" with" better" lifespan," locomotor" and"
synaptic"data,"suggesting"that"PI3K"induced"change"in"aggregation"might"be"beneficial"by"
for"AD."
Previous" studies" consider" fibrillar" insoluble" deposits" of" Aβ42" rather" benign" species"
(DaRocha/Souto"et"al.,"2011,"Moreth"et"al.,"2013)," in"contrast" to"soluble"and"more" toxic"
Aβ42"oligomers."Although"larger"and"more"insoluble"accumulations"could"be"very"difficult"
to" degrade" by" the" three" known" Aβ42" degrading" enzymes:" neprilysin," insulin" degrading"
enzyme"or"endothelium"converting"enzyme"(Turner"et"al.,"2004)"they"have"been"proposed"
to"serve"as"a"sink"for"oligomers.""





conformational" changes," that" in" turn," promote" hemophilic" interactions" and" eventually"
lead" to" Aβ" oligomer" formation." Due" to" these" conformational" changes," the" resulting"
polymers"become"rich"in"β/sheet"structures.""
Besides," post/translationally" modified" Aβ" species" have" been" identified" (Kummer" and"
Heneka," 2014," Kuo" et" al.," 2001)" including" truncation" (Hartig" et" al.," 2010)," racemization"
(Murakami" et" al.," 2008)," isomerization" (Shimizu"et" al.," 2000)," pyroglutamination" (Kuo"et"
al.," 1997)," metal/induced" oxidation" (Dong" and" Bai," 2003)" and" phosphorylation" (Milton,"
2001,"Kumar"et"al.,"2011)."
Phosphorylation" in"particular"can"be"potentially"achieved"at"3"different"sites" in"the"Aβ42"
aminoacid" sequence:" serines" at" position" 8th" and" 26th," and" tyrosine" at" position" 10th." In"
addition,"Aβ"has"been"previously" found" to"undergo"phosphorylation"by"protein"kinase"A"
and"cyclin/dependent"kinase"(cdc)"2" in*vitro" (Milton,"2001)."Specially,"phosphorylation"at"
serine/8" by" protein" kinase" A" was" observed" in" free" extracellular" Aβ" rather" than" in" its"
precursors" (APP" or" β/CTF)" and" promoted" the" formation" of" toxic" aggregates." Also,"
phosphorylated"deposits"from"APP"transgenic"mice"were"found"concentrated"in"the"center"
of" the"plaque" (Kumar"et"al.,"2011)."Phosphorylation" in" this"particular" residue" (ser/8)"has"
been" documented" to" induce" Aβ" resistance" to" degradation" by" insulin" degrading" enzyme"
(Kumar"et"al.,"2012)."
Another" study" described" cdc" 2" phosphorylation" at" residue" serine/26" in" an" in* vitro"
approach" (Milton," 2001)." In" this" case," no" detailed" analysis" was" performed" about" the"
potential" changes" in" aggregation," although" cell" treatment" with" olomoucine" prevented"
cytotoxicity"and"Aβ"phosphorylation,"suggesting"that"aggregative"forms"favored"by"ser/26"
phosphorylation" enhance" Aβ" toxicity." " In" contrast," our" data" suggest" that" PI3K/induced"
phosphorylation" in" ser/26" ameliorates" Aβ" neurodegenerative" effects" and" promotes"
insoluble"Aβ"assemblies"formation."
Recent" in* vitro" analysis" of" Aβ40" phosphorylated" at" ser/26" has" described" that" this"
modification" impairs" fibrillization" while" stabilizing" monomer" and" non/toxic" soluble"
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aggregates."Computational"studies"predicted"that"a"phosphate/group"at"residue"26"could"
rigidify" the" region" and" interfere" with" a" fibril/specific" salt/bridge" (Rezaei/Ghaleh" et" al.,"
2014)."
A" specific" region" in" the" Aβ" sequence" comprising" residues" 25/29" generates" a" bend/like"
structure" that" juxtaposes" the" hydrophobic" faces" of" the" two" cross/β" units." This" bend"
formation"is"important"for"the"pathogenic"aggregation"of"Aβ"(Murray"et"al.,"2009,"Fawzi"et"
al.," 2008)." Other" studies" have" further" emphasized" the" importance" of" the" ‘Glycine" 25" /"
Serine" 26’" dipeptide" in" Aβ42" monomer" structure" organization" by" finding" changes" in"
aggregative" properties" upon" biochemical" modifications" in" these" two" residues"
(Roychaudhuri"et"al.,"2014)."They"have"proposed"a"potential"use"of"drugs"that"could"alter"
the" interactions" of" this" dipeptide" with" neighboring" side/chain" atoms" or" with" the" core"
sequence"of"the"peptide.""




explore" new" therapies" triggering" specific" residue" modifications" like" phosphorylation" or"
dephosphorylation" which," in" turn," could" change" Aβ" aggregation" patterns" to" less" toxic"




can" assert" their" phosphorylation" activities" inside" of" the" cell" or" even" outside" of" the" cell,"
where" they" can" phosphorylate" cell/surface" proteins" or" soluble" extracellular" substrates"
(Redegeld"et"al.,"1999,"Shaltiel"et"al.,"1993,"Walter"et"al.,"1994)."These"Ecto/PKs"and"Exo/
PKs,"that"catalyze"their"activities"at"the"external"cell"surface"or"in"the"extracellular"media"
respectively," can" use" extracellular" ATP," which" is" present" in" the" brain" at" nanomolar"
concentrations" and" can" also" increase" locally" upon" certain" stimuli" (Gourine" et" al.," 2007,"
Melani"et"al.,"2005,"el/Moatassim"et"al.,"1992)."
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Thus," extracellular" phosphorylation" of" Aβ" is" biochemically" possible" by" protein" kinases."
Although" in" depth" studies" are" needed" in" order" to" completely" understand" the" structural"
changes"that"Aβ"phosphorylation"could"have"in"amyloid"aggregation"and"AD"progression."
"
3.! Aβ42! effects! in! non<neuronal! cells.! New! non<synaptogenic! actions! of! PI3K! in! Aβ!
toxicity!
Almost" thirty" years" ago," expression"of"APP" in" non/neuronal" cells"was" first" reported" and"
short" after," secretion" of" its" putative" Aβ" peptides"was" also" described" (Card" et" al.," 1988,"
Busciglio"et" al.," 1993)." Even" so,"until" very" recently," it"was"widely"accepted" that"neurons"
were" the" only" cells" producing" the" majority" of" Aβ" in" an" activity/dependent" manner"
(Kamenetz"et"al.,"2003)."Nowadays,"several"studies"have"demonstrated"that"also"glial"cells:"
astrocytes," oligodendrocytes" and" microglia" play" important" roles" in" AD" pathology" (De"










Aβ42" in" leucokinergic" cells" lead" to" inflated" abdomens," and" epithelial" expression" of" Aβ"
resulted" in" caspase/3" activation," as" well" as" Wnt" signaling" misregulation." Although" it" is"
thought"that"Aβ"affects"cells"differentially," it" is"not"well"understood"what"are"the"factors"
leading"this"cell" specificity."Our"data"suggest" that"even" if" the"mechanistic" features"of"Aβ"




two" mechanisms" also" involved" in" Aβ" degeneration" in" neurons." Interestingly," PI3K"






Taking" together" the" data" presented" in" this" thesis," new" questions" arise" in" order" to" seek"
more"detailed"understanding"of" the"PI3K"actions" in"β/amyloid"neurodegeneration," since"
activation"of"Phosphoinositide/3"kinase"has"shown"to"induce"synaptogenic"protection"and"
aggregative"effects,"but"we"ask"if"both"outcomes"are"related,"being"one"the"consequence"
of" the"other,"or" if" PI3K" synaptogenic" and"aggregation"effects" are" independent."Knowing"
that" other" synaptogenic" strategies," like" Medea" down/expression," also" elicit" Aβ42"
protective" effects," we" wonder" if" in" this" scenario" Aβ42" aggregative" properties" are" also"
affected,"and"then,"what"could"be"triggering"the"aggregation"change?""
Interestingly,"although"PI3K"can" revert" the" loss"of" synapses" to"normal"control"values," its"
actions"are"not" sufficient" to"produce" total" recovery" in" locomotion"and" lifespan."Another"
open" question" arises" asking"what" other" negative" effects" of" Aβ42," if" any," are" not" being"
restored" by" PI3K?" In" the" case" of" Medea" knockdown" experiments," synapses" were" also"
reverted"to"control" levels,"and" locomotion"and"survival"Aβ"effects"are" totally"prevented."
Thus,"is"Medea"downregulation"triggering"better"functional"effects"in"synapses"that"those"
triggered" by" PI3K?" or" is" Medea" downregulation" mediating" other" synaptic/independent"
effects"that"contribute"to"Aβ42"protection?"
Newly" described"deleterious" effects" of"Aβ42" in" neurosecretory" cells" and" epithelial" cells,"
two" non/synaptic" environments," bring" numerous" questions:" Does" Aβ42" affect" epithelial"
and"neurosecretory"cells"in"AD"patients?"Are"those"effects"triggering"the"same"intracellular"
effectors?" Is" Aβ42" affecting" other" cell/to/cell" communication" structures" in" these" non/





Finally," PI3K" actions" in" a" synaptotoxic" scenario" could" also" be" studied" in" other"
neurodegenerative" models" like" Parkinson" disease," amyotrophic" lateral" sclerosis,"
Huntington"disease"or"frontotemporal"dementia."Moreover,"since"many"of"these"diseases"












1. PI3K" overexpression" prevents" Aβ42/induced" synaptic" loss" in" an" age/independent"
manner."
2. Synaptic" protection" by" PI3K" overexpression" restores" microtubule" dynamics;"
however," it" does" not" affect" transcriptional" regulation" of" the" synaptic" proteins"
bruchpilot,"liprin"or"synaptobrevin."
3. PI3K" synaptogenic" actions" delay" the"Aβ42/induced" locomotion" degeneration" and"
lifespan."
4. "PI3K" activation" can" also" elicit" survival" recovery" in" human" neurons" treated" with"
Aβ42"oligomers."
5. Medea" down/expression," but" not" canonical" PI3K" effectors" like" mTOR," prevents"
Aβ42" mediated" synaptic" degeneration" and" recovers" the" β/amyloid" deleterious"
effects."
6. PI3K" overexpression" causes" changes" in" Aβ" aggregation" to" a"more" insoluble" non/
toxic"pattern."
7. PI3K" effect" in" Aβ42" aggregation" is" reproduced" in" in* vitro" studies" with" human"
neurons,"where"PI3K"can"promote"Aβ42"aggregation"outside"of"the"cell."









1. La" sobre/expresión" de" PI3K" previene" la" pérdida" sináptica" inducida" por" Aβ42" de"
manera"independiente"a"la"edad."
"
2. La" protección" sináptica" producida" por" la" sobre/expresión" de" PI3K" restaura" la"






4. La" activación" de" PI3K" produce" la" recuperación" de" la" supervivencia" en" neuronas"
humanas"tratadas"con"oligómeros"de"Aβ42."
"















9. Aβ42" causa" efectos" deletéreos" en" ambientes" no/neuronales," donde" la" sobre/
expresión"de"PI3K"también"es"capaz"de"prevenir"su"toxicidad."
"
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by" the"gray"area" in" the"graph."Aβ" levels" are" the" first"measures" to"be"detected" (red"and"
purple"arrows),"followed"by"tau"(light"blue"arrow),"FDG"PET"and"MRI"(dark"blue"arrow)"and"




not/inherited" forms" of" AD" converge" in" the" accumulation" and" oligomerization" of" Aβ"
species," which" induce" the" progression" of" the" rest" of" events" to" eventually" result" the"




non/amyloidogenic" processing" that" the" full/length" APP" can" suffer." In" the" amyloidogenic"
pathway" (right)" β" and" γ" secretases" sequentially" cut" APP" generating" the" resulting" Aβ"
peptide" (orange" fragment)" and" the" AICD" fragment" (purple)." In" the" non/amyloidogenic"
pathway"(left)"a"different"cleavage"is"accomplished"by"the"α/secretase"first,"and"thus,"the"
resulting" fragment," after" being" processed" by" the" γ/secretase," different" fragments" are"
released,"p3"(orange)"and"AICD"(purple)."(Adapted"from"Nicolas"and"Hassan"2014)."
Fig.! I4! Aβ! aggregates.!Schematic" cartoon" representing" the" different" Aβ" assemblies" that"
can"be"generated"upon"β/amyloid"aggregation."APP" full/length"protein" is" represented" in"
purple,"with"the"Aβ"fragment"in"orange."Arrows"indicate"the"cleavage"elicited"by"β"and"γ"
secretases."The"spectrum"of"Aβ"species"range"from"soluble"monomers"to"insoluble"fibrils"
and" are" known" to" vary" from" less" toxic" assemblies" (green)" to" more" toxic" aggregates"
(orange)."
Fig.! I5! Aβ! effects! in! synaptic! transmission.! Schematic" representation" summarizing" the"
hypothetical" sequential" effects" of" Aβ" in" presynaptic" and" postsynaptic" regulation." " Aβ"
abnormally" low"and"high" levels" impair"synaptic"activity,"but" intermediate" levels"enhance"
synaptic" activity" (a)." In" particular," intermediate" Aβ" levels" affect" presynaptic" and" post/
synaptic"terminals" (b),"but"high"Aβ" levels"regulate"only"postsynaptic"functions"(c)." (Palop"
and"Mucke"2010)."
Fig.! I6! APP! structure! and! domains! across! species.! Schematic" representation" of" APP"
domain"structure"in"Homo*sapiens,"Mus*musculus,"Dario*rerio,"Caenorhabditis*elegans*and"
Drosophila* melanogaster." The" following" domains" are" represented:" Heparin/binding"






Fig.! I7! Location! and! structure! of* Drosophila! neuromuscular! active! zone.! Schematic"
cartoon" representing" the" pre/synaptic" and" post/synaptic" sides" of" a" synapse," and" in"













Fig.! R1! PI3K! activation! prevents! Aβ42! induced! synapse! loss.! (A<D’’)! Representative"
confocal" image" examples" of" Bruchpilot" immunostainings" visualizing" adult" VLM" NMJs"
expressing" UAS/lacZ" (control)," UAS/PI3Kcaax," UAS/Aβ42(2x)," and" UAS/PI3KCAAX/UAS/
Aβ42(2x)"constructs"at"7"(A/D),"15"(A’/D’)"and"25"days"of"expression"(A’’/D’’)"with"elavc155/
Gal4/TubGal80TS." (E)!Quantification" of" synaptic" area" representing" normalized" Bruchpilot"
positive" signal" detected" in" the" immunostainings" of" the" different" genotypes" and" time/
points"shown"in"A/D’’."Results"are"represented"in"dot/blot"diagrams"showing"all"measured"
and" normalized" values." Bars" represent" mean" and" SDM." Statistical" t/test" results" are"
indicated"with"***"p<0,001,"**"p<"0,01"and"*"p<0,05"for"control"group"comparisons,"and"
###" p<0,001," ##" p<0,01" and" #" p<0,05" for" Aβ42" group" comparisons."When" no" statistical"
significance"is"found"p"value"is"indicated."Scale"bar"is"20μm."
Fig.!R2!No!transcriptional!changes!are!found!in!any!of!the!studied!genotypes.!Histograms"
plotting" mRNA" levels" of" bruchpilot" (A)," liprin" (B)" and" synaptobrevin" (C)" measured" by"
quantitative"RT/PCR"in"15"days/old"adult"brains"of"the"indicated"genotypes"expressed"with"
elavc155/Gal4/TubGal80ts." Results" are" represented"as" fold" induction"with" respect" to"UAS/
lacZ" (control)" group" (red" dotted" line)." Error" bars" represent" SDM." Comparisons" between"
groups"correspond"to"t/test"analysis.!
Fig.! R3! PI3K! prevents! Aβ42<induced! microtubule! dynamics! deficits.! (A)! Schematic"
cartoon" depicting"microtubule" growth" and" shrinking" processes" noting" the" presences" of"










Fig.!R4!Aβ42<induced! locomotion!activity! reduction! is!delayed!by!PI3K!overexpression.!
(A)" Schematic" cartoon" representing" the" three" fly" populations" considered" in" the"
locomotion"analysis."(B<E)"Histograms"showing"standardized"values"of"the"number"of"flies"
climbing" to" the" top"of" the" tube" (blue)," climbing" the" tube"but"not" reaching" the"4cm" line"
(orange),"and"staying"at" the"bottom"of" the" tube" (black)."UAS/lacZ" (control)" (B,F,G),"UAS/




Fig.! R5! PI3K! expression! increases! lifespan! of! Aβ42! flies.! (A<E)! Survival" curves" for" the"
following" genotypes:" PI3K" (A,E);" Aβ42" (B,D,E);" and" PI3K/Aβ42" (C,D,E)" compared" to" lacZ"
(control)"genotype"(black"lines"in"A/C),"or"compared"to"Aβ42"genotype"(D)"expressing"the"
corresponding" UAS" constructs" with" elavc155/Gal4/TubGal80TS." (E)" Survival" curve"
representing" survival" data" in" all" genotypes." Statistical" analysis" with" Mantel/Cox" test" is"
shown"as"****"p<0,0001.""
Fig.!R6!PI3K!activation!in!human!neurons!prevents!the!cell!survival!reduction!induced!by!
Aβ42." HTSY/5Y" cells" differentiated" (retinoic" acid" 10μM)" and" treated" with" increasing"
concentrations" of" Aβ42" oligomers" (18μg/ml," 36μg/ml" and" 72μg/ml)" for" 48h," and" PTD4/
PI3KAc" peptide" (50μg/ml)" at" different" time/points:" 24" hours" before" Aβ42" oligomers"
(pretreatment),"at"the"same"time"that"Aβ42"oligomers"(co/treatment),"and"24"hours"after"
Aβ42" oligomers" (post/treatment)." Data" from" Cell" Titer" Glo" luminescence" is" shown" as"
percent" viability" and" compared" to" control" values" of" non/treated" cells" (red/dotted" line)."
Error" bars" indicate" SDM." Statistical" significance" is" represented" from" t/test" analysis" with"
***"p<0,001,"**"p<"0,01"and"*"p<0,05."
Fig.!R7!Synaptogenic!proteins,!but!not! canonical!PI3K!effectors,!prevent!Aβ42<induced!
synapse! loss." (A<F)! Representative" confocal" image" examples" of" Bruchpilot"
immunostainings"visualizing"adult"VLM"NMJs"expressing"UAS/lacZ"(control)"(A),"UAS/mTOR"
(B)," UAS/MedeaRNAi" (C)," UAS/Aβ42(2x)" (D)," UAS/mTOR/UAS/Aβ42(2x)" (E)," and" " UAS/
MedeaRNAi/" UAS/Aβ42(2x)" (F)" constructs" with" elavc155/Gal4/TubGal80TS" at" 15" days." (G)!
Quantification" of" synaptic" area" representing" normalized" Bruchpilot" positive" signal"
detected" in" the" immunostainings" of" the" different" genotypes" in" A/F." Results" are"
represented" in" dot/blot" diagrams" showing" all" measured" and" normalized" values." Bars"
represent"mean"and"SDM."Statistical"t/test"results"are" indicated"with"***"p<0,001,"**"p<"
0,01" and" *" p<0,05" for" control" group" comparisons," and" ###" p<0,001," ##" p<0,01" and" #"
p<0,05" for"Aβ42"group"comparisons."When"no" statistical" significance" is" found"p" value" is"
indicated."Scale"bar"is"20μm."
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Fig.! R8! Aβ42<induced! locomotor! decline! is! prevented! by! Medea! knockdown.! (A)!




(B,G,H)," UAS/mTOR" (C,I,J)," UAS/mTOR/UAS/Aβ42(2x)" (D,K)," UAS/MedeaRNAi" (E,L,M)," and""
UAS/MedeaRNAi/" UAS/Aβ42(2x)" (F,N,O)" constructs" expressed" with" elavc155/
Gal4/TubGal80TS."(G<O)!Pie"chart"diagrams"representing"detailed"percent"values"at"15"days"
(G,I,K,L,N)"and"20"days"(H,J,M,O)."
Fig.! R9! Medea! downexpression! blocks! the! Aβ42<induced! lifespan! reduction.! (A<G)!
Survival"curves"for"the"following"genotypes:"UAS/mTOR"(A,G);"UAS/MedeaRNAi"(C,G),"UAS/
Aβ42(2x)" (E,F,G);" UAS/mTOR/UAS/Aβ42(2x)" (B,E,G)," and" " UAS/MedeaRNAi/" UAS/Aβ42(2x)"
(D,F,G);" compared" to" UAS/lacZ" (control)" genotype" (black" lines" in" A/D)," or" compared" to"
Aβ42" genotype" (E/F)." Constructs" are" expressed"with"elavc155/Gal4/TubGal80TS" driver." (G)"
Survival"curve"representing"survival"data"in"all"genotypes."Statistical"analysis"with"Mantel/
Cox"test"is"shown"as"****"p<0,0001."
Fig.! R10! PI3K! activation! increases! Aβ42! levels! without! affecting! transcription.! (A<D)!
Representative"confocal" image"examples"of"Aβ"(white)" immunostainings"visualizing"adult"
brains" expressing" UAS/lacZ" (control)" (A)," UAS/PI3Kcaax" (B)," UAS/Aβ42(2x)" (C)," and" UAS/
PI3KCAAX/UAS/Aβ42(2x)" (D)" constructs" at" 15" with" elavc155/Gal4/TubGal80TS." (E)!
Representative" immunoblot" indicating" Aβ" levels" in" control," Aβ42" and" PI3K/Aβ42" adult"
heads"corresponding"to"the"same"time/point"and"genotypes"used"for"immunostainings"(A/
D)."Histogram" represents"mean"Aβ" levels" quantified" and" normalized" to" tubulin" of" three"
independent"Western/blots."Error"bars"indicate"SDM."(F)"Histograms"plotting"mRNA"levels"
of" Aβ! measured" by" quantitative" RT/PCR" in" 15" days/old" adult" brains" of" the" indicated"
genotypes" expressed" with" elavc155/Gal4/TubGal80ts." Results" are" represented" as" fold"
induction"with" respect" to"Aβ42"group."Error"bars" represent"SDM."Comparisons"between"
groups"correspond"to"t/test"analysis."
Fig.! R11! PI3K! overexpression! increases! Aβ42! insoluble! fraction.! (A)! Schematic" cartoon"
showing" the" different" Aβ" conformers" generated" upon" β" and" γ" secretases" processing" of"
APP." Aggregates" range" from" soluble" to" insoluble" and" differ" in" toxicity" from" less" toxic"
species"(green)"to"more"toxic"assemblies"(orange)."(B<C’)!Representative"confocal" images"
of" thioflavin" stainings" visualizing" 7" days" (B,C)" and" 15" days" (B’," C’)" adult" brains" of" the"
following" genotypes:" UAS/Aβ42(2x)" (B/B’)," and" UAS/PI3KCAAX/UAS/Aβ42(2x)" (C,C’)" with"
elavc155/Gal4/TubGal80TS" driver." (D)" Histograms" representing" thioflavin" staining"
quantification."Data"are"shown"as"mean"Aβ"levels"normalized"with"respect"to"Aβ42"group."
Error"bars" represent"SDM."Comparisons"between"groups"correspond"to"t/test"analysis."*"
p<0,05.! (E)! Representative" immunoblot" indicating" insoluble" Aβ" levels" in" control," PI3K,"
Aβ42" and" PI3K/Aβ42" adult" heads" of" 15" days/old" flies." Histogram" represents" mean" Aβ"
levels" quantified" and" normalized" to" tubulin" of" three" independent" Western/blots." Error"
bars"indicate"SDM."
Fig.!R12!PI3K<induced!Aβ42!aggregation!changes!are!reproduced!in!human!neurons.!(A)!
Schematic" cartoon" representing" the" experimental" design" in" HT/SY5Y" cells" differentiated"
(retinoic"acid"10μM)"and"treated"with"Aβ42"oligomers"(36μg/ml)"and"PTD4/PI3KAc"peptide"
! 97"
(50μg/ml)" for" 48h." (B<D)!Histograms" representing"percent" values"of" number"of" deposits"
(B),"total"deposit"area"(C)"and"deposit"size"distribution"(D)"of"PI3K/Aβ42"and"Aβ42"treated"
cells."Statistical" t/test" results"are" indicated"with"*"p<0,05." (E<H’)!Representative"confocal"
images" showing"Aβ" (green)"and"DAPI" (magenta)" immunostainings."Merged" (E/H)"and"Aβ"
signal"(E’/H’)"images"represent"Aβ"deposits"for"the"indicated"treatments."
Fig.!R13!PI3K<induced!changes!in!Aβ42!aggregation!can!be!reproduced!outside!of!cells.!





Fig.! R14! pSer<Aβ42! increases! following! PI3K! overexpression.! (A)! Scheme" representing"
Aβ42"sequence"and"the"Net/Phos"predicted"residues"for"potential"phosphorylations."(B<E’)!
Representative"confocal"images"of!p/serine"(green)"and"DAPI"(magenta)"immunostainings"
visualizing"15"days/old"adult"brains"of" the" following"genotypes:"UAS/lacZ" (control)" (B,B’),"
UAS/PI3Kcaax"(C,C’),"UAS/Aβ42(2x)"(D,D’),"and"UAS/PI3KCAAX/UAS/Aβ42(2x)"(E,E’)"constructs"
with" elavc155/Gal4/TubGal80TS" driver." (F<I’)!Representative" confocal" images" of!p/tyrosine"
(green)" and"DAPI" (magenta)" immunostainings" visualizing"15"days/old" adult"brains"of" the"
following" genotypes:" UAS/lacZ" (control)" (F,F’)," UAS/PI3Kcaax" (G,G’)," UAS/Aβ42(2x)" (H,H’),"
and"UAS/PI3KCAAX/UAS/Aβ42(2x)"(I,I’)"constructs"with"elavc155/Gal4/TubGal80TS"driver."Scale"
bar"is"10μm."
Fig.! R15! PI3K! specifically! triggers! Ser26<Aβ42! phosphorylation.! (A<B’’’)! Representative"
confocal" images" of! p.Ser26/Aβ42" (green)," p.Ser8/Aβ42" (red)" and" DAPI" (magenta)"
immunostainings" visualizing" 15" days/old" adult" brains" of" the" following" genotypes:" UAS/"
UAS/Aβ42(2x)" (A/A’’’)," and" UAS/PI3KCAAX/UAS/Aβ42(2x)" (B/B’’’)" constructs" with" elavc155/
Gal4/TubGal80TS"driver." (A´/A’’’,"B/B’’’)" show"magnified" images" for"both"genotypes"Scale"
bar"is"50μm"in"(B)"and"10μm"in"(B’)."
Fig.! R16! Aβ42<induced! inflated! abdomen! phenotype! is! prevented! by! PI3K!
overexpression.! (A)! Representative" images" of" 15" days/old" adult" flies" expressing" the"
following" UAS" constructs:" UAS/lacZ" (control)," UAS/Aβ42(2x)," UAS/PI3KCAAX" and" UAS/
PI3KCAAX/UAS/Aβ42(2x)"with"elavc155/Gal4/TubGal80TS"driver."(B)"Lateral"views"of"Aβ42"and"




brains" (A,A’)" and" wing" discs" (B,B’)." (C<D’)" Still" images" of" G/TRACE" pattern" from" early"






Gal4" insertions," chromosome" III" (E/F)" and" chromosome" II" (H/I)." (K<L’)! Representative"
98"




the! first! 12h! after! egg<laying.! (A)! Schematic" representation" of" experimental" design."
Crosses"were"set"and"maintained"24"hours"at"25°C."Then,"first"instar"larvae"were"placed"at"
17°C" (expression" system"OFF)" or" at" 29°C" (expression" system"ON)" for" the" indicated" time"
points:" Always" at" 17°C" “OFF”," 48h," 24h" or" 12h" at" 17°C" or" always" at" 29°C" “ON”." (B<H)!
Representative" images" of" temporal" expression" experiments" in"D428Gal4>G8TRACE>elav8
Gal80TS"brain" (B,C))"and"wing"discs" (D/H)"maintained"at"17°C"“OFF”" (Gal4"silenced),"48h,"
24h"or"12h"OFF"or"maintained"at"29°C"“ON”"(Gal4"active)."(I)"Quantification"(n=5)"of"GFP/
positive"cells"per"time"point."Statistical"t/test"analysis"is"represented"with""*"p<0,05.!
Fig.! R19! Toll26! gene! product! is! not! necessary! for! wing! disc! development.! (A<F)!
Representative"images"of"Caspase"3"activation"(green)"(C3)"and"Wingless"expression"(red)"
and" DAPI" (blue)" immunostainings" in" wild" type" (A/B)," D42/Gal4>Toll6RNAi" (C/D)" and"D428
Gal4>Bsk" " (E/F)" genotypes." (G<I)" Representative" images" of" resulting" adult" wings" in" wild"
type"(G),"D42/Gal4>Toll6RNAi"(H),"and"D428Gal4>Bsk"(I)"genotypes.!
Fig.! R20! Adult! wing! defects! in! Aβ42! flies! are! restored! by! PI3K! overexpression.!
Representative" images"of"adult" fly"wings"of" the" following"genotypes:"UAS/lacZ" (control),"
UAS/PI3KCAAX,"UAS/Aβ42(2x)"and"UAS/PI3KCAAX/UAS/Aβ42(2x)"with"D42/Gal4"driver.!
Fig.!R21!PI3K!overexpression! reduces!Aβ42<induced!apoptosis! in!epithelial! cells!of! the!
wing! disc.! (A<D’)! Representative" confocal" images" of" caspase/3" (A’/B’)" and" phospho/
histone/3"(C’/D’)"and"DAPI"(magenta)" immunostainings"from"third"instar" larval"wing"discs"
expressing" UAS/Aβ42(2x)" and" UAS/PI3KCAAX/Aβ42(2x)" with" engrailed/Gal4/UAS/GFPnls"
driver"that"expresses"GFP"in"the"affected"nuclei"(green)"(A/B,C/D)."
Fig.! R22! PI3K! overexpression! restores! Wnt! signaling! impairment! caused! by! Aβ42! in!
epithelial!cells!of!the!wing!disc.!(A<D’)!Representative"confocal"images"of"wingless"(A’/B’)"
and"armadillo" (C’/D’)" and"DAPI" (magenta)" immunostainings" from" third" instar" larval"wing"






Aβ" region" indicate" changes" that" lead" to" an" increase" in"Aβ"production" (blue),"modify"Aβ"
biophysical"characteristics"(black),"or"alter"Aβ"spectrum"(green)"(Benilova"et"al,"2012)."
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